<!-- ------------------ HEADER ------------------ -->
<!-- Developed and maintained by Jos&eacute; Miguel Lorenzo Salazar
<!-- Researcher on Human Genetics working at the Genomics Division
<!-- of the Institute of Technology an Renewable Energy (ITER)
<!-- Tenerife, Canary Islands, SPAIN
<!-- See the "Contact us" section to collaborate with us to growth
<!-- this repository. ;=)

<!-- ------------------ SECTION ------------------ -->
<p align="left">
  <a href="https://www.iter.es" title="Instituto Tecnológico y de Energ&iacute;as Renovables (ITER) / Institute of Technology and Renewable Energy (ITER)">
    <img src="https://www.iter.es/wp-content/uploads/2016/05/logo.png" width="30%" />
  </a>
</p>

# COVID-19
A public repository of scientific and media resources of SARS-CoV-2 related COVID-19 maintained by ITER.

<hr>
<!-- ------------------ SECTION ------------------ -->

> May 2, 2020 updates: a new major update with 86 new entries and a new section on Book chapters, as follows: Book chapters (5), Clinical (1), Data sources (1), Diagnostics (16), Epidemiology (12), Genomics (9), Journal COVID-19 hubs (5), Maths (1), Respirators and other PPE (1), Projects and Calls (2), Media (1), PCR and related stuff (11), Preprints and Published literature (1), Seroprevalence (9), Viral mechanisms (10), and Education (2). Enjoy the reading! ;=)

> As the repository has largely increased its size, it is also available in <a href="https://github.com/genomicsITER/COVID-19/wiki">WIKI format here</a> for your convenience.

> Use the "Home" button to move up between sections and the ToC.

# Table of contents #
<ul>
  <li><a href="#Books chapters">Books chapters</a></li>
  <li><a href="#Clinical Trials and Pharmacological Treatments">Clinical Trials and Pharmacological Treatments</a></li>
  <li><a href="#Diagnostics">Diagnostics</a></li>
  <li><a href="#Educational resources">Educational resources</a></li>
  <li><a href="#Epidemiology">Epidemiology</a></li>  
  <li><a href="#Genomics and Phylodynamics of SARS-CoV-2">Genomics and Phylodynamics of SARS-CoV-2</a></li>
  <li><a href="#Guidelines, Society's Clinical and Professional Statements">Guidelines, Society's Clinical and Professional Statements</a></li>
  <li><a href="#Media sources">Media sources</a></li>
  <li><a href="#Protocols">Protocols</a></li>
  <li><a href="#Rapid Tests">Rapid Tests</a></li>
  <li><a href="#Research Coalitions and Funding Calls">Research Coalitions and Funding Calls</a></li>
  <li><a href="#Respirators, masks, and other Personal Protective Equipments (PPE)">Respirators, masks, and other Personal Protective Equipments (PPE)</a></li>

  <li><a href="#Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)" >Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)</a></li>
  <ul>
    <li><a href="#Maths and Epidemiological Models">Maths and Epidemiological Models </a></li>
    <li><a href="#PCR related articles">PCR related articles</a></li>
  </ul>
  <li><a href="#Sciencific Data and Resources" >Sciencific Data and Resources</a></li>
  <ul><li><a href="#Autonomous Regions and Cities in Spain" >Autonomous Regions and Cities in Spain</a></li></ul>
    <li><a href="#Seroprevalence">Seroprevalence</a></li>  
  <li><a href="#Sequencing, Sequences and Bioinformatics">Sequencing, Sequences and Bioinformatics</a></li>
  <li><a href="#Shiny and R related dashboards and packages">Shiny and R related dashboards and packages. Under construction</a></li>  
  <li><a href="#Viral mechanisms and Tropism">Viral mechanisms: infection, entry, and replication. Under construction</a></li>
  <li><a href="#Acknowledgements">Acknowledgements</a></li>
  <li><a href="#Contact us">Contact us</a></li>
  <li><a href="https://github.com/genomicsITER/COVID-19/blob/master/CONTRIBUTING.md">Contributing to this repository</a></li>
  <li><a href="https://github.com/genomicsITER/COVID-19/blob/master/CODE_OF_CONDUCT.md">Code of Conduct</a></li>
  <li><a href="#Update logs">Update logs</a></li>
  </ul>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Book chapters"></a>
## Book chapters ##
> New section on May 2, 2020.

[Coronaviruses, Chapter 31, Fenner and White's Medical Virology (Fifth Edition (Elsevier's Academic Press, 2017)](https://www.sciencedirect.com/science/article/pii/B978012375156000031X)

[Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), Chapter 155, Mandell, Douglas, and Bennett's Principles and Practice of Infectious 
Diseases, Ninth Edition (Elsevier, 2020)](https://www.elsevier.com/__data/assets/pdf_file/0009/976302/Coronaviruses_Perlman-and-McIntosh_155.pdf)

[Disaster Epidemiology and Surveillance, Chapter 27, Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health, 5th Edition (Elsevier, 2020)](https://www.elsevier.com/__data/assets/pdf_file/0009/1006299/Jekels-Chaper-27_Disaster-Epidemiology-and-Surveillance.pdf)

[Novel Coronavirus from Wuhan China, 2019-20, Update to Chapter 155, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, Ninth Edition (Elsevier, 2020)](https://www.elsevier.com/__data/assets/pdf_file/0006/976299/PPID_Ch155_Update_1-31-2020.pdf)

[Viral Infections, Chapter 32, Murray and Nadel’s Textbook of Respiratory Medicine, Sixth Edition (Elsevier, 2016)](https://reader.elsevier.com/reader/sd/pii/B9781455733835000324?token=67B23BFF342DBCDCD464EE88FC0F0540987B2C18E2398E0F72CCD9D5A8AABFF9BBE2EBFBF1B839A9C7F9D2E40C0C27FE)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Clinical Trials and Pharmacological Treatments"></a>
## Clinical Trials and Pharmacological Treatments ##
> Section to show on-going clinical trials to figth against COVID-19

[U.S. National Library of Medicine, ClinicalTrials.gov, Clinical Trials ordered by treatment](https://clinicaltrials.gov/ct2/results?cond=COVID&term=&cntry=&state=&city=&dist=)

<ul>

<li><a href="https://clinicaltrials.gov/ct2/results?term=anakinra&cond=COVID">Anakinra clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=azithromycin&cond=COVID">Azithromycin clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=baricitinib&cond=COVID">Baricitinib clinical trials</a></li>
 
<li><a href="https://clinicaltrials.gov/ct2/results?term=cobicistat&cond=COVID">Cobicistat clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=colchicina&cond=COVID">Colchicina clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=darunavir&cond=COVID">Darunavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=hydrychloroquine&cond=COVID">Hydrychloroquine clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=interferon&cond=COVID">Interferon clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=lopinavir&cond=COVID">Lopinavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=remdesivir&cond=COVID">Remdesivir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=ritonavir&cond=COVID">Ritonavir clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=sarilumab&cond=COVID">Sarilumab clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=siltuximab&cond=COVID">Siltuximab clinical trials</a></li>

<li><a href="https://clinicaltrials.gov/ct2/results?term=tocilizumab&cond=COVID">Tocilizumab clinical trials</a></li>

</ul>


[Clinical Trials in Spain](https://clinicaltrials.gov/ct2/results?cond=COVID-19&term=&cntry=ES&state=&city=&dist=&Search=Search)

[European Union Clinical Trials Register, Clinical trials for COVID-19](https://www.clinicaltrialsregister.eu/ctr-search/search?query=covid-19)

[Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). A review](https://jamanetwork.com/journals/jama/fullarticle/2764727)

[Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status](https://www.sciencedirect.com/science/article/pii/S1567134820301581)

[STAT's Covid-19 Drugs and Vaccines Tracker](https://www.statnews.com/feature/coronavirus/drugs-vaccines-tracker/)

[WHO DRAFT landscape of COVID-19 candidate vaccines, now includes two Spanish pre-clinical trials (April 11)](https://www.who.int/blueprint/priority-diseases/key-action/Novel_Coronavirus_Landscape_nCoV_11April2020.PDF)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Diagnostics"></a>
## Diagnostics ##

> New section on April 26, 2020.

[A case of a readmitted patient who recovered from COVID-19 in Chengdu, China](https://ccforum.biomedcentral.com/articles/10.1186/s13054-020-02877-8)

[Chest CT findings of COVID-19 pneumonia by duration of symptoms](https://www.sciencedirect.com/science/article/pii/S0720048X20301984)

[Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past](https://www.sciencedirect.com/science/article/pii/S1386653220301049)

[COVID-19 diagnosis and study of serum SARS-CoV-2 specific IgA, IgM and IgG by a quantitative and sensitive immunoassay](https://www.medrxiv.org/content/10.1101/2020.04.17.20064907v1)

[Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?](https://www.sciencedirect.com/science/article/pii/S0720048X20301509)

[Distinguishing COVID-19 from influenza pneumonia in the early stage through CT imaging and clinical features](https://www.medrxiv.org/content/10.1101/2020.04.17.20061242v1)

[Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting SARS-CoV-2](https://www.sciencedirect.com/science/article/pii/S1525157820300908)

[Imaging of coronavirus disease 2019: A Chinese expert consensus statement. Review](https://www.sciencedirect.com/science/article/pii/S0720048X20301972)

[Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection](https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25725)

[Failed detection of the full-length genome of SARS-CoV-2 by ultra-deep sequencing from the recovered and discharged patients retested viral PCR positive](https://www.medrxiv.org/content/10.1101/2020.03.27.20043299v1)

[Positive RT-PCR Test Results in Patients Recovered From COVID-19](https://jamanetwork.com/journals/jama/fullarticle/2762452)

[Positive RT-PCR tests among discharged COVID-19 patients in Shenzhen, China](https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology/article/positive-rtpcr-tests-among-discharged-covid19-patients-in-shenzhen-china/87EC1B29B2C3EE6730F4CF795DB4F7D7)

[Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility](https://www.nejm.org/doi/full/10.1056/NEJMoa2008457)

[Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens](https://jamanetwork.com/journals/jama/fullarticle/2764787)

[SARS-CoV-2-Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19](https://www.ncbi.nlm.nih.gov/pubmed/32227141)

[SARS-CoV-2 Infection in Children](https://www.nejm.org/doi/full/10.1056/NEJMc2005073)

[SARS-CoV-2 turned positive in a discharged patient with COVID-19 arouses concern regarding the present standard for discharge](https://www.ijidonline.com/article/S1201-9712(20)30126-0/pdf)

[Serial CT features in discharged COVID-19 patients with positive RT-PCR re-test](https://www.ejradiology.com/article/S0720-048X(20)30199-6/fulltext)

[Seven discharged patients turning positive again for SARS-CoV-2 on quantitative RT-PCR](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151314/)



<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Educational resources"></a>
## Educational resources ##

[Actualización sobre la situación de la COVID-19, Dr. Josep Maria Miró](https://www.youtube.com/watch?v=VcURN4NnaJI)

[#AprendeBioinformáticaEnCasa](https://bioinfogp.cnb.csic.es/courses/quedateencasa/)

[Así es la lucha entre el sistema inmune y el coronavirus. El País](https://elpais.com/elpais/2020/04/20/ciencia/1587379836_984471.html)


[Bioinformatics Training Resources for Experimentalists (and Friends)](https://jasondk.github.io/bioinformatics-edu/)

[COVID19: Top 7 online interactive simulations, curated](https://towardsdatascience.com/covid19-top-7-online-interactive-simulations-curated-fa4282889875)

[COVID-19 Preparedness for Radiotherapy Departments - Towards Consensus on Best Practices](https://humanhealth.iaea.org/HHW/)
<p align="center">
    <a href="https://humanhealth.iaea.org/HHW/" title="See this resource">
      <img src="https://humanhealth.iaea.org/HHW/resources/images/product-name.png" width="40%"/>
    </a> 
</p>

[Czech campaign #masks4all](https://docs.google.com/document/u/0/d/1EWpWmyjzM4sNBF-7jp_1Y9a-pqiRg0wakGXy7kj11RA/mobilebasic)
[We need #masks4all, in Youtube](https://youtu.be/BoDwXwZXsDI)

[Harvard Medical School MEDICAL STUDENT COVID-19 CURRICULUM](https://docs.google.com/document/d/13JfRRw1GEIKz4JCde8WcQBCHnu-7nn11P_z0dHov1eA/preview#)

[IAEA International Atomic Energy Agency webinar, COVID-19 and chest CT: protocol and dose optimization](https://www.iaea.org/resources/webinar/covid-19-and-chest-ct-protocol-and-dose-optimization)
<p align="center">
    <a href="https://www.iaea.org/resources/webinar/covid-19-and-chest-ct-protocol-and-dose-optimization" title="See this resource">
      <img src="https://www.iaea.org/sites/default/files/iaea-logo.png" width="40%"/>
    </a> 
</p>

[Infectious Disease Modelling: Beyond the Basic SIR Model](https://towardsdatascience.com/infectious-disease-modelling-beyond-the-basic-sir-model-216369c584c4)

[International AIDS Society COVID-19 and HIV: Webinar series: "COVID-19 and HIV: What you need to know"](https://www.iasociety.org/HIV-Programmes/Cross-cutting-issues/COVID-19-and-HIV-Webinars)

[Los virus más infecciosos del último siglo, en imágenes, diario El País, España](https://elpais.com/elpais/2020/04/14/album/1586870301_739813.html)

[SARS-CoV-2 (COVID-19) by the n. EPIDEMIOLOGY AND GLOBAL HEALTH MICROBIOLOGY AND INFECTIOUS DISEASE elife](https://elifesciences.org/articles/57309)

[The race for coronavirus vaccines: a graphical guide](https://www.nature.com/articles/d41586-020-01221-y)

[The woman who discovered the first coronavirus](https://www.bbc.com/news/uk-scotland-52278716)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Epidemiology"></a>
## Epidemiology ##

[A “One-Health” approach for diagnosis and molecular characterization of SARS-CoV-2 in Italy](https://www.sciencedirect.com/science/article/pii/S2352771420300823)

[Analysis of the impact of lockdown on the evolution Covid-19 epidemics in Spain](https://www.medrxiv.org/content/10.1101/2020.04.18.20070862v1)

[BCG VACCINES MAY NOT REDUCE COVID-19 MORTALITY RATES](https://www.medrxiv.org/content/10.1101/2020.04.11.20062232v1)

[COVID-19 Asymptomatic Infection Estimation](https://www.medrxiv.org/content/10.1101/2020.04.19.20068072v1)

[COVID-19 Disease Dynamics in Germany: First Models and Parameter Identification](https://www.medrxiv.org/content/10.1101/2020.04.23.20076992v1)

[COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020](https://wwwnc.cdc.gov/eid/article/26/7/20-0764-f1)

[Early detection of superspreaders by mass group pool testing can mitigate COVID-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.22.20076166v1)

[Estimating the probability of New Zealand regions being free from COVID-19 using a stochastic SEIR model](https://www.medrxiv.org/content/10.1101/2020.04.20.20073304v1)

[Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China](https://www.medrxiv.org/content/10.1101/2020.03.03.20030593v1)

[How did SARS-CoV-19 spread in India from Italy, Iran and China? Genetic surveillance of early cases and virus demography](https://www.biorxiv.org/content/10.1101/2020.04.26.062406v1)

[INTRODUCTIONS ET CIRCULATION INITIALE DU SARS-COV-2 EN FRANCE](https://www.pasteur.fr/fr/espace-presse/documents-presse/introductions-circulation-initiale-du-sars-cov-2-france)

[Modeling infectious epidemics](https://www.nature.com/articles/s41592-020-0822-z)

[Outbreak dynamics of COVID-19 in Europe and the effect of travel restrictions](https://www.medrxiv.org/content/10.1101/2020.04.18.20071035v1)

[Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis. JAMA editorial | Infectious Diseases](https://jamanetwork.com/journals/jama/fullarticle/2764656)

[Relationship between COVID-19 death toll doubling time and national BCG vaccination policy](https://www.medrxiv.org/content/10.1101/2020.04.06.20055251v2)

[Temporal variation in transmission during the COVID-19 outbreak](https://epiforecasts.io/covid/reports.html)

[The fate of house cats during the COVID-19 pandemic](https://www.sciencedirect.com/science/article/pii/S1286457920300733)

[The incubation period of COVID-19: A rapid systematic review and meta-analysis of observational research](https://www.medrxiv.org/content/10.1101/2020.04.24.20073957v1)

[Why does COVID-19 case fatality rate vary among countries?](https://www.medrxiv.org/content/10.1101/2020.04.17.20069393v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Genomics and Phylodynamics of SARS-CoV-2"></a>
## Genomics and Phylodynamics of SARS-CoV-2 ##
> Section devoted to show main findings in the virus genome.

[A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Repurposing](https://www.biorxiv.org/content/10.1101/2020.03.22.002386v3)

[An 81 base-pair deletion in SARS-CoV-2 ORF7a identified from sentinel surveillance in Arizona (Jan-Mar 2020)](https://www.medrxiv.org/content/10.1101/2020.04.17.20069641v1)

[A New Resource for Genomics and Precision Health Information and Publications on the Investigation and Control of COVID-19 and other Coronaviruses](https://www.biorxiv.org/content/10.1101/2020.04.21.050922v1)

[Characterization of intra-host SARS-CoV-2 variants improves phylogenomics reconstruction and may reveal functionally convergent mutations](https://www.biorxiv.org/content/10.1101/2020.04.22.044404v1)

[Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site](https://www.biorxiv.org/content/10.1101/2020.03.22.002204v1)

[Comparative ACE2 variation and primate COVID-19 risk](https://www.biorxiv.org/content/10.1101/2020.04.09.034967v1)

[Comparative transcriptome analysis reveals the intensive early-stage responses of host cells to SARS-CoV-2 infection](https://www.biorxiv.org/content/10.1101/2020.04.30.071274v1)

[Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Isolated in Nepal](https://mra.asm.org/content/9/11/e00169-20)

[CoV-GLUE. Virus genome analysis for the SARS-CoV-2 pandemic](http://cov-glue.cvr.gla.ac.uk/)

[COVID-19 Cell Atlas](https://www.covid19cellatlas.org/)

[CovProfile: profiling the viral genome and gene expressions of SARS-COV2](https://www.biorxiv.org/content/10.1101/2020.04.05.026146v1)

[Direct RNA sequencing and early evolution of SARS-CoV-2](https://www.biorxiv.org/content/10.1101/2020.03.05.976167v2)

[Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility](https://journals.physiology.org/doi/full/10.1152/physrev.00013.2020)

[Emergence of multiple variants of SARS-CoV-2 with signature structural changes](https://www.biorxiv.org/content/10.1101/2020.04.26.062471v1)

[Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic](https://www.biorxiv.org/content/10.1101/2020.03.30.015008v1)

[Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses](https://www.biorxiv.org/content/10.1101/2020.04.05.026450v1)

[Genomic diversity of SARS-CoV-2 in Coronavirus Disease 2019 patients](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa203/5780800)

[Gene expression and in situ protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissue](https://www.biorxiv.org/content/10.1101/2020.04.07.030742v1)

[Genomic variations of SARS-CoV-2 suggest multiple outbreak sources of transmission](https://www.medrxiv.org/content/10.1101/2020.02.25.20027953v2)

[Global patterns in coronavirus diversity](https://academic.oup.com/ve/article/3/1/vex012/3866407)

[How fast does the SARS-Cov-2 virus really mutate in heterogeneous populations?](https://www.medrxiv.org/content/10.1101/2020.04.23.20076075v1)

[In-depth Bioinformatic Analyses of Human SARS-CoV-2, SARS-CoV, MERS-CoV, and Other Nidovirales Suggest Important Roles of Noncanonical Nucleic Acid Structures in Their Lifecycles](https://www.biorxiv.org/content/10.1101/2020.04.09.031252v1)

[Knowledge synthesis from 100 million biomedical documents augments the deep expression profiling of coronavirus receptors](https://www.biorxiv.org/content/10.1101/2020.03.24.005702v1.full.pdf)

[LAMP-Seq: Population-Scale COVID-19 Diagnostics Using a Compressed Barcode Space](https://www.biorxiv.org/content/10.1101/2020.04.06.025635v1)

[MERS-CoV recombination: implications about the reservoir and potential for adaptation](https://academic.oup.com/ve/article/2/1/vev023/1753363)

[Nanopore target sequencing for accurate and comprehensive detection of SARS-CoV-2 and other respiratory viruses](https://www.medrxiv.org/content/10.1101/2020.03.04.20029538v1)

[Phylodynamics of SARS-CoV-2 transmission in Spain](https://www.biorxiv.org/content/10.1101/2020.04.20.050039v1)

[Proyecto Epidemiologia Genomica COVID 19](https://evosalut1.uv.es/)

[Proyecto SeqCOVID – Genomic epidemiology of SARS-CoV-2 in Spain](http://seqcovid.csic.es/)

[Quality control of low-frequency variants in SARS-CoV-2 genomes](https://www.biorxiv.org/content/10.1101/2020.04.26.062422v1)

[Reproducible analyses for rejecting rare genomic inversions in SARS-CoV-2](https://github.com/alexcritschristoph/sars_cov_2_inversion)

[REVEALING COVID-19 TRANSMISSION BY SARS-CoV-2 GENOME SEQUENCING AND AGENT BASED MODELLING](https://www.biorxiv.org/content/10.1101/2020.04.19.048751v1)

[RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak](https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1725399)

[SARS coronavirus 2 in Viral Zone / Covid-19 genome expression](https://viralzone.expasy.org/9076)

[SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies](https://www.biorxiv.org/content/10.1101/2020.03.27.009480v1)

[SARS-CoV-2 Receptor ACE2 is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Enriched in Specific Cell Subsets Across Tissues](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3555145)

[Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter protein structure, dynamics and thus function: Effect on viral RNA replication](https://www.biorxiv.org/content/10.1101/2020.04.26.063024v1)

[Synonymous mutations and the molecular evolution of SARS-Cov-2 origins](https://www.biorxiv.org/content/10.1101/2020.04.20.052019v1)

[The architecture of SARS-CoV-2 transcriptome](https://www.biorxiv.org/content/10.1101/2020.03.12.988865v2)

[The genomic variation landscape of globally-circulating clades of SARS-CoV-2 defines a genetic barcoding scheme](https://www.biorxiv.org/content/10.1101/2020.04.21.054221v1)

[The proximal origin of SARS-CoV-2](https://www.nature.com/articles/s41591-020-0820-9)

[The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like motif](https://www.biorxiv.org/content/10.1101/2020.04.09.033522v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>
<!-- ------------------ END of GENOMICS SECTION ------------------ -->



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Guidelines, Society's Clinical and Professional Statements"></a>
## Guidelines
> A colection of guides and documents from different natianal and international institutions with means to protect people againts COVID-19, including biosafety guidelines, decontamination recommendations and risks, etc. 
> The opinions expressed in there do not reflect ITER institutional position.

[CEN and CENELEC make European standards available to help prevent the COVID-19 contagion](https://www.cencenelec.eu/News/Press_Releases/Pages/PR-2020-003.aspx)
<p align="center">
    <a href="https://www.cencenelec.eu/News/Press_Releases/Pages/PR-2020-003.aspx" title="See this resource">
      <img src="https://www.cencenelec.eu/_layouts/1033/STYLES/CENCENELECResponsive/img/device-cen-cenelec.gif" width="40%"/>
    </a> 
</p>

[Documento de posicionamiento de la SEIMC sobre el diagnóstico microbiológico de COVID-19](https://seimc.org/contenidos/documentoscientificos/recomendaciones/seimc-rc-2020-Posicionamiento_SEIMC_diagnostico_microbiologico_COVID19.pdf)

[European CDC, Considerations relating to social distancing measures in response to COVID-19 – second update](https://www.ecdc.europa.eu/en/publications-data/considerations-relating-social-distancing-measures-response-covid-19-second)
<p align="center">
    <a href="https://www.ecdc.europa.eu/en/publications-data/considerations-relating-social-distancing-measures-response-covid-19-second" title="See this resource">
      <img src="https://www.ecdc.europa.eu/profiles/custom/ecdc/themes/anthrax/images/logo-ecdc.png" width="25%"/>
    </a> 
</p>

[Fichas InfoSEV de la Sociedad Española de Virología con información básica para dar respuesta a las preguntas más frecuentes sobre el coronavirus SARS-CoV-2 y la enfermedad COVID-19](http://sevirologia.es/2020/04/02/infosev-preguntas-y-respuestas-sobre-covid-9-y-sars-cov-2/)

[Novel Coronavirus (COVID-19): The American Thoracic Society (ATS) Response](https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/novel-coronavirus.php)
<p align="center">
    <a href="https://www.thoracic.org/professionals/clinical-resources/disease-related-resources/novel-coronavirus.php" title="See this resource">
      <img src="https://www.thoracic.org/_files/images/logoats.jpg" width="40%"/>
    </a> 
</p>

[Recommended Guidance for Extended Use and Limited Reuse of N95 Filtering Facepiece Respirators in Healthcare Settings](https://www.cdc.gov/niosh/topics/hcwcontrols/recommendedguidanceextuse.html)

[Recomendaciones Institucionales de la Sociedad Española de Enfermedades Infeccionas y Microbiología Clínica (SEIMC)](https://seimc.org/documentos-cientificos/recomendaciones-institucionales) 

[USA CDC Clean & Disinfect
Interim Recommendations for US Households with Suspected/Confirmed Coronavirus Disease 2019](https://www.cdc.gov/coronavirus/2019-ncov/prepare/cleaning-disinfection.html) 

[SemiSyuc](https://semicyuc.org/covid-19/#Documentos)     |     [Plan de Contingencia para los Servicios de Medicina Intensiva frente a la pandemia COVID-19](https://semicyuc.org/wp-content/uploads/2020/03/Plan-Contingencia-COVID-19.pdf) 

[WHO Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts](https://www.who.int/publications-detail/home-care-for-patients-with-suspected-novel-coronavirus-(ncov)-infection-presenting-with-mild-symptoms-and-management-of-contacts)

[WHO several guidelines to protect Workers Health](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/health-workers)

[WHO Laboratory biosafety guidance related to coronavirus disease (COVID-19) interim guidance, 19 March 2020:](https://apps.who.int/iris/handle/10665/331500)
<p align="center">
    <a href="https://apps.who.int/iris/handle/10665/331500" title="See this resource">
      <img src="https://apps.who.int/iris/themes/WHO//images/en/who_logo.svg" width="30%"/>
    </a> 
</p>

[WHO - Laboratory Biosafety Manual - Third Edition](https://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/) 

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Media sources"></a>
## Media sources
> Selected media articles because of their informative content.
> The opinions expressed in there do not reflect ITER institutional position.

[Así es la lucha entre el sistema inmune y el coronavirus. El País, España](https://elpais.com/elpais/2020/04/20/ciencia/1587379836_984471.html)

[COVID-19: Why we should all wear masks — There is new scientific rationale](https://medium.com/@Cancerwarrior/covid-19-why-we-should-all-wear-masks-there-is-new-scientific-rationale-280e08ceee71)

[El Cabildo de Tenerife aporta una máquina de análisis de COVID-19](http://www.diariodetenerife.info/el-cabildo-de-tenerife-aporta-una-maquina-de-analisis-de-covid-19-que-hace-50-pruebas-por-hora/)

[Example of a device using UV-C for decontamination](https://www.tmghealthtech.com/rds-32) 

[Example of a Rapid Bio Decontamination Service, from Bioquell](https://www.bioquell.com/life-sciences/systems-and-services/decontamination/?lang=en-uk) 

[Everything we know about coronavirus immunity and antibodies — and plenty we still don’t](https://www.statnews.com/2020/04/20/everything-we-know-about-coronavirus-immunity-and-antibodies-and-plenty-we-still-dont)

[Financial Times](https://www.ft.com/coronavirus-latest) 

[How did Spain get its coronavirus response so wrong?](https://www.theguardian.com/world/2020/mar/26/spain-coronavirus-response-analysis)

[How sewage could reveal true scale of coronavirus outbreak](https://www.nature.com/articles/d41586-020-00973-x)

[Investigadores del ITER y de La Candelaria aceleran el método de diagnóstico del Covid-19](http://www.diariodetenerife.info/investigadores-del-iter-y-de-la-candelaria-aceleran-el-metodo-de-diagnostico-del-covid-19/)

[Los sesgos que engañan al cerebro durante la pandemia, El País](https://elpais.com/ciencia/2020-03-26/los-sesgos-que-enganan-al-cerebro-durante-la-pandemia.html) 

[Mount Sinai to Begin the Transfer of COVID-19 Antibodies into Critically Ill Patients](https://inside.mountsinai.org/blog/mount-sinai-to-begin-the-transfer-of-covid-19-antibodies-into-critically-ill-patients/)

[NYT, Bad News Wrapped in Protein: Inside the Coronavirus Genome](https://www.nytimes.com/interactive/2020/04/03/science/coronavirus-genome-bad-news-wrapped-in-protein.html)

[Over 24,000 coronavirus research papers are now available in one place](https://www.technologyreview.com/s/615367/coronavirus-24000-research-papers-available-open-data/)

[The Ibuprofen Debate Reveals the Danger of Covid-19 Rumors](https://www.wired.com/story/the-ibuprofen-debate-reveals-the-danger-of-covid-19-rumors/) 

[Rockefeller-Led Team Launches Initiative to Study COVID-19 Genetic Vulnerability (GenomeWeb)](https://www.genomeweb.com/infectious-disease/rockefeller-led-team-launches-initiative-study-covid-19-genetic-vulnerability)

[We've never made a successful vaccine for a coronavirus before. This is why it's so difficult](https://www.abc.net.au/news/health/2020-04-17/coronavirus-vaccine-ian-frazer/12146616)

[Why It’s So Freaking Hard To Make A Good COVID-19 Model](https://fivethirtyeight.com/features/why-its-so-freaking-hard-to-make-a-good-covid-19-model/)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Protocols"></a>
## Protocols ##

[Shared SARS-COV-2 DIAGNOSTIC PIPELINES at FinDX](https://www.finddx.org/covid-19/pipeline/)
<p align="center">
    <a href="https://www.finddx.org/covid-19/pipeline/" title="See this resource">
      <img src="https://www.finddx.org/wp-content/themes/find/img/logo_header.svg" width="15%"/>
    </a> 
</p>

[WHO Coronavirus disease (COVID-19) technical guidance: Laboratory testing for 2019-nCoV in humans (Updated March 25, 2020)](https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance) [In-house developed molecular assays, not validated, probably still under development, but not necessarily updated here](https://www.who.int/docs/default-source/coronaviruse/whoinhouseassays.pdf?sfvrsn=de3a76aa_2)

<ul>
<li>
<a href="http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html" title="See this resorce">China CDC Primers and probes for detection 2019-nCoV (24 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2" title="See this resorce">Diagnostic detection of Wuhan coronavirus 2019 by real-time RT-PCR – Charité, Berlin Germany (17 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/peiris-protocol-16-1-20.pdf?sfvrsn=af1aac73_4" title="See this resorce">Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by RT-PCR – Hong Kong University (23 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/conventional-rt-pcr-followed-by-sequencing-for-detection-of-ncov-rirl-nat-inst-health-t.pdf?sfvrsn=42271c6d_4" title="See this resorce">PCR and sequencing protocol for 2019-nCoV - Department of Medical Sciences, Ministry of Public Health, Thailand (Updated 28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/method-niid-20200123-2.pdf?sfvrsn=fbf75320_7" title="See this resorce">PCR and sequencing protocols for 2019-nCoV- National Institute of Infectious Diseases Japan (24 January 2020)</a>
  </li>
<li>
<a href="https://www.fda.gov/media/134922/download" title="See this resorce">US CDC Real-Time RT-PCR Panel for Detection 2019-Novel Coronavirus (28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/uscdcrt-pcr-panel-primer-probes.pdf?sfvrsn=fa29cb4b_2" title="See this resorce">US CDC panel primer and probes– U.S. CDC, USA (28 January 2020)</a>
  </li>
<li>
<a href="https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2" title="See this resorce">Real-time RT-PCR assays for the detection of SARS-CoV-2 Institut Pasteur, Paris (2 March 2020)</a>
  </li>
</ul>

<hr>

[A Massively Parallel COVID-19 Diagnostic Assay for Simultaneous Testing of 19200 Patient Samples, in Twitter](https://twitter.com/hsalis/status/1241121806473461760?s=20)  | [Protocol](https://t.co/x2c2v8uvw3?amp=1) | [Primers & Spike-in Controls](https://t.co/9cWzQrfz5P?amp=1)

[Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow](https://www.medrxiv.org/content/10.1101/2020.03.07.20032326v1) 

[Chinese Center for Disease and Control and Prevention](http://www.chinacdc.cn/en/COVID19/)
[China CDC Real-time RT-PCR protocol](http://www.chinacdc.cn/en/COVID19/202003/P020200323390496137554.pdf)

[Broad Institute](https://www.broadinstitute.org/files/publications/special/COVID-19%20detection%20(updated).pdf) 

[NIID Japan](https://www.niid.go.jp/niid/en/2019-ncov-e/9334-ncov-vir3-2.html)
[Detection of second case of 2019-nCoV infection in Japan](https://www.niid.go.jp/niid/en/examination.html)

[SwabSeq. Allows for detection of SARS-COV-2 genomic RNA, without purification, in a single-step RT-PCR followed by sequencing. By OctanBio](https://github.com/octantbio/SwabSeq)

[USA CDC Center for Disease and Control Coronavirus Disease 2019 (COVID-19)](https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Flab%2Frt-pcr-detection-instructions.html) [RT-PCR protocol](https://www.fda.gov/media/134922/download) 

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Rapid Tests"></a>
## Rapid Tests ##
> Section to highlight contributions to rapid tests production and testing.

[COVID-19: immunopathology and its implications for therapy](https://www.nature.com/articles/s41577-020-0308-3)

[Diagnostic Testing for Severe Acute Respiratory Syndrome–Related Coronavirus-2: A Narrative Review](https://annals.org/aim/fullarticle/2764737/diagnostic-testing-severe-acute-respiratory-syndrome-related-coronavirus-2-narrative)

[Fast, portable tests come online to curb coronavirus pandemic, Nature. See table inside](https://www.nature.com/articles/d41587-020-00010-2)

[Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies](https://www.medrxiv.org/content/10.1101/2020.04.10.20061150v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- SECTION -->

<a name="Research Coalitions and Funding Calls"></a>
## Research Coalitions and Funding Calls ##
> Section to collect open calls in the research funding arena.

[CaixaImpulse COVID-19 Call for projects that address the COVID-19 emergency open until 15 April](https://caixaimpulse.com/programme?program_id=PROGRAMME_COVID_19)

[COG-UK COVID Genomics UK Consortium](https://www.cogconsortium.uk)
<p align="center">
    <a href="https://www.cogconsortium.uk">
      <img src="https://www.cogconsortium.uk/wp-content/themes/cogconsortium/dist/assets/svg/logos/logo-cog-uk.png" width="30%"/>
    </a> 
</p>

[COVID-19 Clinical Research Coalition](https://covid19crc.org/)
<p align="center">
    <a href="https://covid19crc.org/">
      <img src="https://covid19crc.org/wp-content/uploads/2020/04/Logo-COVID19_CRC_web.png" width="30%"/>
    </a> 
</p>

[COVID Human Genetic Effort](https://www.covidhge.com/)
<p align="center">
    <a href="https://www.covidhge.com/">
      <img src="https://images.squarespace-cdn.com/content/v1/5e7bb93fa060854b1a204f9a/1585618859125-Q41LFBN0HJ30OTPJC2FT/ke17ZwdGBToddI8pDm48kHf62bRcj8g5xu3PjqRtWb5Zw-zPPgdn4jUwVcJE1ZvWQUxwkmyExglNqGp0IvTJZUJFbgE-7XRK3dMEBRBhUpzVvhhfg18jv7JFa1V4i-BVDEgkDMV135pHH45GHFhanv1h3j41qTAPGVXHKsjsg_U/COVID+Human+Genetic+Effort+Logo?format=750w" width="20%"/>
    </a> 
</p>

[COVID-19 Host Genetics Initiative](https://www.covid19hg.org/)
<p align="center">
    <a href="https://www.covid19hg.org/">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/COVID19_hg_project.png" width="20%"/>
    </a> 
</p>

[COVID-19 Testing Project](https://covidtestingproject.org/index.html)

[COVID-Zero Coalition](https://wellcome.ac.uk/what-we-do/our-work/coronavirus-covid-19/investment/covid-zero)
<p align="center">
    <a href="https://wellcome.ac.uk/what-we-do/our-work/coronavirus-covid-19/investment/covid-zero">
      <img src="https://wellcome.ac.uk/sites/default/files/covid-zero-header-03.jpg" width="230%"/>
    </a> 
</p>

[Crue Universidades Españolas, CSIC y Banco Santander lanzan el FONDO SUPERA COVID-19](http://www.crue.org/Comunicacion/Noticias/FONDOsuperaCOVID19.aspx)

[European Comission Funding & tender opportunities Single Electronic Data Interchange Area (SEDIA)](https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/covid-19)

[European Research Council List of ERC-funded Research Projects related to coronavirus](https://erc.europa.eu/list-erc-funded-research-projects-related-coronavirus)

[European Comission Coronavirus research and innovation. Research and innovation projects and initiatives to tackle the spread of coronavirus and preparedness for other outbreaks](https://ec.europa.eu/info/research-and-innovation/research-area/health-research-and-innovation/coronavirus-research_en)

[Fast Funding for COVID-19 Science](https://fastgrants.org/)

[Solicitud urgente de Expresiones de Interés para la financiacin extraordinaria de proyectos de investigacin sobre el SARS-CoV-2 y la enfermedad COVID-19, Ministerio de Ciencia e Innovacin, España](https://www.isciii.es/QueHacemos/Financiacion/Paginas/SolicitudExpresionesInteresCoVid19.aspx#new_tab?utm_source=rss&utm_medium=rss&utm_campaign=solicitud-urgente-de-expresiones-de-interes-para-la-financiacion-extraordinaria-de-proyectos-de-investigacion-sobre-el-sars-cov-2-y-la-enfermedad-covid19)

[SPHERES. USA-CDC SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology and Surveillance (SPHERES)](https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/spheres.html)

[The Open COVID Pledge](https://opencovidpledge.org/)
<p align="center">
    <a href="https://opencovidpledge.org/" title="See this resource">
      <img src="https://opencovidpledge.org/wp-content/uploads/OCP_Logos/cropped-OCP_WP_logo_240x240.png" width="20%"/>
    </a> 
</p>

[WHO The Global Preparedness Monitoring Board](https://apps.who.int/gpmb/)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Respirators, masks, and other Personal Protective Equipments (PPE)"></a>
## Respirators, masks, and other Personal Protective Equipments (PPE)
> A selection of websites to understand what a respirator or a mask is, and what are the differences between the different personal protective equipments.

[Analysis of SteraMist ionized hydrogen peroxide technology as a method for sterilizing N95 respirators and other personal protective equipment](https://www.medrxiv.org/content/10.1101/2020.04.19.20069997v1)

[Aerosolized Hydrogen Peroxide Decontamination of N95 Respirators, with Fit-Testing and Virologic Confirmation of Suitability for Re-Use During the COVID-19 Pandemic](https://www.medrxiv.org/content/10.1101/2020.04.17.20068577v1)

[Assessment of N95 respirator decontamination and re-use for SARS-CoV-2](https://www.medrxiv.org/content/10.1101/2020.04.11.20062018v1)

[Association of Personal Protective Equipment Use with Successful Protection Against COVID-19 Infection Among Health Care Workers](https://www.medrxiv.org/content/10.1101/2020.04.24.20070169v1)

[Can N95 respirators be reused after disinfection? And for how many times?](https://www.medrxiv.org/content/10.1101/2020.04.01.20050443v1)

[Clarificación de los diferentes tipos de mascarillas, Ministerio de Sanidad](https://www.redaccionmedica.com/contenido/images/1_clarificacion_diferentes_tipos_mascarillas.pdf)

[Comparison of nanoparticle filtration performance of NIOSH-approved and CE-marked particulate filtering facepiece respirators](https://www.ncbi.nlm.nih.gov/pubmed/19261695)

[Comparison of FFP2, KN95, and N95 and Other Filtering Facepiece Respirator Classes](https://multimedia.3m.com/mws/media/1791500O/comparison-ffp2-kn95-n95-filtering-facepiece-respirator-classes-tb.pdf) 

[Effect of various decontamination procedures on disposable N95 mask integrity and SARS-CoV-2 infectivity](https://www.medrxiv.org/content/10.1101/2020.04.11.20062331v1)

[Efficacy of face mask in preventing respiratory virus transmission: a systematic review and meta-analysis](https://www.medrxiv.org/content/10.1101/2020.04.03.20051649v1)

[Face Masks Against COVID-19: An Evidence Review](https://www.preprints.org/manuscript/202004.0203/v1)

[Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.04.20052696v1)

[Guías para la fabricación de mascarillas y ropa de protección, Ministerio de Sanidad](https://www.mincotur.gob.es/es-es/COVID-19/Paginas/guias-para-fabricacion-de-mascarillas-y-ropa-de-proteccion.aspx)

[Marcado CE de las mascarillas, Ministerio de Industrial, Comercio y Turismo](https://www.mincotur.gob.es/es-es/COVID-19/GuiaFabricacionEPIs/2_mascarillas_tipo_EPI_como_legalizarlas_v2.0.pdf)

[N95 Mask Decontamination using Standard Hospital Sterilization Technologies](https://www.medrxiv.org/content/10.1101/2020.04.05.20049346v1)

[N95 Respirators and Surgical Masks (Face Masks)](https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks)

[Publicada la Especificación UNE para facilitar la fabricación de mascarillas higiénicas reutilizables](https://www.une.org/la-asociacion/sala-de-informacion-une/noticias/especificacion-une-mascarillas)     |     [Descarga directa de PDF](https://www.mincotur.gob.es/es-es/COVID-19/GuiaFabricacionEPIs/Especificacion%20UNE%20Mascarillas%20higienicas%20reutilizables/Especificacion_UNE_0065_mascarillas_higienicas_reutilizables.pdf)

[UV light dosage distribution over irregular respirator surfaces. Methods and implications for safety](https://www.medrxiv.org/content/10.1101/2020.04.07.20057224v1)

[Ventilators are in high demand for Covid-19 patients. How do they work?](https://www.statnews.com/2020/03/30/covid-19-ventilators-how-they-work/)

[Widespread use of face masks in public may slow the spread of SARS CoV-2: an ecological study](https://www.medrxiv.org/content/10.1101/2020.03.31.20048652v1)

[Nonmedical Masks in Public for Respiratory Pandemics: Droplet Retention by two-layer Textile Barrier Fully Protects Germ-free Mice from Bacteria in Droplets](https://www.biorxiv.org/content/10.1101/2020.04.06.028688v1)

[Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 - Face masks, eye protection and person distancing: systematic review and meta-analysis](https://www.medrxiv.org/content/10.1101/2020.03.30.20047217v2)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)"></a>
## Scientific Communications and Literature (Pre-prints & Peer-Reviewed Papers)
> Reminder. Notice that a number of these papers might be preliminary reports that have not been peer-reviewed. 
> They should not be regarded as conclusive, guide clinical practice/health-related behavior, or be reported in news media as established information.
<br />

[Cell Press Coronavirus Resource Hub](https://www.cell.com/COVID-19)

[COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv](https://connect.medrxiv.org/relate/content/181)
<p align="center">
    <a href="https://connect.medrxiv.org/relate/content/181" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/medRxiv-bioRxiv.png" width="40%"/>
    </a> 
</p>

[Coronavirus: Research, Commentary, and News | Science | AAAS](https://www.sciencemag.org/collections/coronavirus)

[COVID-19 Preprints](https://covid19preprints.app/)

[ELSEVIER Novel Coronavirus Resource Directory](https://www.elsevier.com/novel-coronavirus-covid-19) | [ELSEVIER Novel Coronavirus Information Center](https://www.elsevier.com/connect/coronavirus-information-center)
> Download full text for data-mining: server: sftp://public@coronacontent.np.elsst.com | user: public | pass: beat_corona

[ERS COVID-19 resource centre](https://www.ersnet.org/the-society/news/novel-coronavirus-outbreak--update-and-information-for-healthcare-professionals)

[NEJM Journal Watch](https://www.jwatch.org/covid-19)

<hr>

[REACTing research & action targeting emerging infectious diseases web portal. Selection of the most relevant articles published on COVID-19 on a bi-weekly basis. France](https://reacting.inserm.fr/literature-review/)

[SemanticScholar COVID-19 Open Research Dataset (CORD-19)](https://pages.semanticscholar.org/coronavirus-research)
<p align="center">
    <a href="https://pages.semanticscholar.org/coronavirus-research" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CORD-19.png" width="40%"/>
    </a> 
</p>

<hr>

[A case of SARS-CoV-2 carrier for 32 days with several times false negative nucleic acid tests](https://www.medrxiv.org/content/10.1101/2020.03.31.20045401v1)

[A contingency plan for the management of the 2019 novel coronavirus outbreak in neonatal intensive care units](https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30040-7/fulltext) 

[A new coronavirus associated with human respiratory disease in China](https://www.nature.com/articles/s41586-020-2008-3?WT.ec_id=NATURE-20200312) 

[A Novel Coronavirus from Patients with Pneumonia in China, 2019](https://www.nejm.org/doi/10.1056/NEJMoa2001017) 

[Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1](https://www.nejm.org/doi/full/10.1056/NEJMc2004973) 

[Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards, Wuhan, China, 2020](https://doi.org/10.3201/eid2607.200885)

[A pneumonia outbreak associated with a new coronavirus of probable bat origin](https://www.nature.com/articles/s41586-020-2012-7?WT.ec_id=NATURE-20200312) 

[A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://www.nejm.org/doi/full/10.1056/NEJMoa2001282) 

[An international comparison of the second derivative of COVID-19 deaths after implementation of social distancing measures](https://www.medrxiv.org/content/10.1101/2020.03.25.20041475v1)

[An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice](https://stm.sciencemag.org/content/early/2020/04/03/scitranslmed.abb5883)

[Blueprint for a Pop-up SARS-CoV-2 Testing Lab](https://www.medrxiv.org/content/10.1101/2020.04.11.20061424v1)

[Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy](https://jamanetwork.com/journals/jama/fullarticle/2763667) 

[CDC Coronavirus Disease 2019 (COVID-19) publications](https://www.cdc.gov/coronavirus/2019-ncov/publications.html) 

[Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding](https://doi.org/10.1038/s41591-020-0817-4) 

[Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCR Testing](https://pubs.rsna.org/doi/10.1148/radiol.2020200343)

[Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30566-3/fulltext) 

[Clinical Characteristics of Coronavirus Disease 2019 in China](https://www.nejm.org/doi/full/10.1056/NEJMoa2002032) 

[Clinical characteristics of the recovered COVID-19 patients with re-detectable positive RNA test](https://www.medrxiv.org/content/10.1101/2020.03.26.20044222v1)

[Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan,China](https://doi.org/10.1093/cid/ciaa272) 

[Clinical and virological data of the first cases of COVID-19 in Europe: a case series](https://www.sciencedirect.com/science/article/pii/S1473309920302000?via%3Dihub)

[Coronavirus Disease 2019: Coronaviruses and Blood Safety](https://doi.org/10.1016/j.tmrv.2020.02.003) 

[Coronavirus Disease 2019 (COVID-19) in Italy](https://jamanetwork.com/journals/jama/fullarticle/2763401) 

[Coronavirus Disease 2019 and Influenza](https://jamanetwork.com/journals/jama/fullarticle/2762386) 

[Coronavirus Infections—More Than Just the Common Cold](https://jamanetwork.com/journals/jama/fullarticle/2759815) 

[COVID-19 in Singapore—Current Experience: Critical Global Issues That Require Attention and Action](https://jamanetwork.com/journals/jama/fullarticle/2761890)

[COVID-19: what is next for public health?](https://doi.org/10.1016/S0140-6736(20)30374-3) 

[Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy. Early Experience and Forecast During an Emergency Response](https://jamanetwork.com/journals/jama/fullarticle/2763188)

[Cutaneous manifestations in COVID‐19: a first perspective](https://onlinelibrary.wiley.com/doi/10.1111/jdv.16387)

[Detection of SARS-CoV-2 in Different Types of Clinical Specimens](https://jamanetwork.com/journals/jama/fullarticle/2762997) 

[Dermatology staff participate in fight against Covid-19 in China](https://onlinelibrary.wiley.com/doi/abs/10.1111/jdv.16390)

[Diagnosis of Acute Respiratory Syndrome Coronavirus 2 Infection by Detection of Nucleocapsid Protein](https://www.medrxiv.org/content/10.1101/2020.03.07.20032524v2)

[Direct RNA nanopore sequencing of full-length coronavirus genomes provides novel insights into structural variants and enables modification analysis](https://europepmc.org/article/MED/31439691) 

[Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia](https://www.nejm.org/doi/full/10.1056/NEJMoa2001316) 

[Early warnings of novel coronavirus from genomic epidemiology and the global open scientific response](https://bedford.io/blog/genomic-epi-for-ncov-response/) 

[Exploring possible mechanisms for COVID‐19 induced thrombocytopenia: Unanswered Questions](https://onlinelibrary.wiley.com/doi/abs/10.1111/jth.14832)

[Estimation of the percentages of asymptomatic patients and undiagnosed patients of the novel coronavirus (SARS-CoV-2) infection in Hokkaido, Japan by using birth-death process with recursive full tracing](https://www.medrxiv.org/content/10.1101/2020.04.06.20053934v1)

[Estimating the number of infections and the impact of nonpharmaceutical interventions on COVID-19 in 11 European countries](https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf)

[Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding](https://www.sciencedirect.com/science/article/pii/S0140673620302518) 

[Human leukocyte antigen susceptibility map for SARS-CoV-2](https://www.medrxiv.org/content/10.1101/2020.03.22.20040600v1)

[Identifying SARS-CoV-2 related coronaviruses in Malayan pangolins](https://www.nature.com/articles/s41586-020-2169-0)

[Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV](https://www.sciencedirect.com/science/article/pii/S1201971220302046)

[Is low dose radiation therapy a potential treatment for COVID-19 pneumonia?](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30304-4/fulltext)

[Loss of smell and taste in combination with other symptoms is a strong predictor of COVID-19 infection](https://www.medrxiv.org/content/10.1101/2020.04.05.20048421v1)

[Managing neonates with respiratory failure due to SARS-CoV-2](https://www.thelancet.com/journals/lanchi/article/PIIS2352-4642(20)30073-0/fulltext) 
[Novel 2019 coronavirus genome](http://virological.org/t/novel-2019-coronavirus-genome/319) 

[Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia](https://academic.oup.com/clinchem/advance-article/doi/10.1093/clinchem/hvaa029/5719336) 

[Nature Special Report. Special report: The simulations driving the world’s response to COVID-19. How epidemiologists rushed to model the coronavirus pandemic](https://www.nature.com/articles/d41586-020-01003-6)

[Novel Coronavirus Infection in Newborn Babies Under 28 Days in China](https://erj.ersjournals.com/content/early/2020/04/01/13993003.00697-2020)

[NIID National Institute for Infectious Diseases Manual for the Detection of Pathogen 2019-nCoV](https://www.niid.go.jp/niid/en/examination/9493-labmanual-en.html) 

[Potent Antiviral Activities of Type I Interferons to SARS-CoV-2 Infection](https://www.biorxiv.org/content/10.1101/2020.04.02.022764v2)

[Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens](https://jamanetwork.com/journals/jama/fullarticle/2764787)

[Rational use of face masks in the COVID-19 pandemic](https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30134-X)

[Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases](https://pubs.acs.org/doi/10.1021/acscentsci.0c00272) 

[Respiratory virus shedding in exhaled breath and efficacy of face masks](https://www.nature.com/articles/s41591-020-0843-2)

[SARS-CoV-2 detection from nasopharyngeal swab samples without RNA extraction](https://www.biorxiv.org/content/10.1101/2020.03.28.013508v1)

[SARS-CoV-2 neutralizing serum antibodies in cats: a serological investigation](https://www.biorxiv.org/content/10.1101/2020.04.01.021196v1)

[Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations](https://wwwnc.cdc.gov/eid/article/26/7/20-0839_article)

[Spread of SARS-CoV-2 in the Icelandic Population](https://www.nejm.org/doi/full/10.1056/NEJMoa2006100)

[Stability of the COVID-19 virus under wet, dry and acidic conditions](https://www.medrxiv.org/content/10.1101/2020.04.09.20058875v1)

[Structural Basis for the Inhibition of the RNA-Dependent RNA Polymerase from SARS-CoV-2 by Remdesivir](https://www.biorxiv.org/content/10.1101/2020.04.08.032763v2)

[Structure of the RNA-dependent RNA polymerase from COVID-19 virus](https://science.sciencemag.org/content/early/2020/04/09/science.abb7498)

[Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2](https://www.biorxiv.org/content/10.1101/2020.03.30.015347v1)

[Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)](https://science.sciencemag.org/content/early/2020/03/24/science.abb3221)

[Temporal dynamics in viral shedding and transmissibility of COVID-19](https://www.nature.com/articles/s41591-020-0869-5)

[The convalescent sera option for containing COVID-19](https://www.jci.org/articles/view/138003/pdf)

[The trinity of COVID-19: immunity, inflammation and intervention](https://www.nature.com/articles/s41577-020-0311-8)

[Three Emerging Coronaviruses in Two Decades
The Story of SARS, MERS, and Now COVID-19](https://academic.oup.com/ajcp/article/153/4/420/5735509) 

[Toilets dominate environmental detection of SARS-CoV-2 virus in a hospital](https://www.medrxiv.org/content/10.1101/2020.04.03.20052175v1)

[Transcriptional Inhibition of Host Viral Entry Proteins as a Therapeutic Strategy for SARS-CoV-2](https://www.preprints.org/manuscript/202003.0360/v1)

[Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany](https://www.nejm.org/doi/full/10.1056/NEJMc2001468) 

[Understanding of COVID-19 based on current evidence](https://www.ncbi.nlm.nih.gov/pubmed/32096567) 

[Universal Screening for SARS-CoV-2 at Delivery Could Identify Many Asymptomatic Women](https://www.nejm.org/doi/full/10.1056/NEJMc2009316)

[Validation of a Lysis Buffer Containing 4 M Guanidinium Thiocyanate (GITC)/ Triton X-100 for Extraction of SARS-CoV-2 RNA for COVID-19 Testing: Comparison of Formulated Lysis Buffers Containing 4 to 6 M GITC, Roche External Lysis Buffer and Qiagen RTL Lysis Buffer](https://www.medrxiv.org/content/10.1101/2020.04.05.20049346v1)
[Virological assessment of hospitalized patients with COVID-2019](https://www.nature.com/articles/s41586-020-2196-x)

<!--
[]()
[]()
[]()
[]()
[]()
[]()
[]()
-->

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SUBSECTION ------------------ -->

<a name="Maths and Epidemiological Models"></a>
## Maths and Epidemiological Models
> Subsection dedicated to PCR (RT-qPCR) and related topics.
<br />

[A Path to the End of COIVD-19 - a Mathematical Model](https://www.medrxiv.org/content/10.1101/2020.04.17.20069443v1)

[An SEIR Model for Assessment of Current COVID-19 Pandemic Situation in the UK](https://www.medrxiv.org/content/10.1101/2020.04.12.20062588v1)

[Estimating the impact of mobility patterns on COVID-19 infection rates in 11 European countries](https://www.medrxiv.org/content/10.1101/2020.04.13.20063644v1)

[Flattening the curve before it flattens us: hospital critical care capacity limits and mortality from novel coronavirus (SARS-CoV2) cases in US counties - 3 and 6 week projections from April 2, 2020](https://behcolumbia.files.wordpress.com/2020/04/flattening-the-curve-before-it-flattens-us-20200405b.pdf)

[How you can help with COVID-19 modelling](https://www.nature.com/articles/s42254-020-0175-7)

[Mask use, hand hygiene, and seasonal influenza-like illness among young adults: A randomized intervention trial](https://academic.oup.com/jid/article/201/4/491/861190)

[Mathematical Modeling of the Effectiveness of Facemasks in Reducing the Spread of Novel Influenza A (H1N1)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2818714/)

[Modelo para el estudio de la dinámica de transmisión del SARS-CoV-2 y la enfermedad COVID19. Descripción técnica](https://covid19.webs.upv.es/INFORMES/Explicacion_tecnica.pdf)

[Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period](https://science.sciencemag.org/content/early/2020/04/14/science.abb5793)

[Reproductive numbers, epidemic spread and control in a community of households](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731010/)

[Swiss Medical Weekly - Potential impact of seasonal forcing on a SARS-CoV-2 pandemic](https://doi.org/10.4414/smw.2020.20224)

[Sustainable social distancing through facemask use and testing during the Covid-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.01.20049981v1)

[The Immediate Effect of COVID-19 Policies on Social Distancing Behavior in the United States](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3571421)

[The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany, 2009-2011](https://bmcinfectdis.biomedcentral.com/articles/10.1186/1471-2334-12-26)

[The use of facemasks to prevent respiratory infection: a literature review in the context of the Health Belief Model](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293989/)

[Unraveling R0: Considerations for Public Health Applications](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935673/)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SUBSECTION ------------------ -->

<a name="PCR related articles"></a>
## PCR related articles and other detection techniques

> Subsection dedicated to PCR (RT-qPCR) and related topics.
<br />

[A protocol for massively parallel diagnosis and genome sequencing of SARS-CoV-](https://www.protocols.io/view/a-protocol-for-massively-parallel-diagnosis-and-ge-betrjem6)

[A rapid, low cost, and highly sensitive SARS-CoV-2 diagnostic based on whole genome sequencing](https://www.biorxiv.org/content/10.1101/2020.04.25.061499v1)

[A Scalable, Easy-to-Deploy, Protocol for Cas13-Based Detection of SARS-CoV-2 Genetic Material](https://www.biorxiv.org/content/10.1101/2020.04.20.052159v1)

[A simple colorimetric molecular detection of novel coronavirus (COVID-19), an essential diagnostic tool for pandemic screening](https://www.medrxiv.org/content/10.1101/2020.04.10.20060293v1)

[A streamlined approach to rapidly detect SARS-CoV-2 infection, avoiding RNA extraction](https://www.medrxiv.org/content/10.1101/2020.04.06.20054114v1)

[An alternative workflow for molecular detection of SARS-CoV-2 - escape from the NA extraction kit-shortage](https://www.medrxiv.org/content/10.1101/2020.03.27.20044495v1)

[Analysis of factors associated early diagnosis in coronavirus disease 2019 (COVID-19)](https://www.medrxiv.org/content/10.1101/2020.04.09.20059352v1)

[Analytical sensibility and specificity of two RT-qPCR protocols for SARS-CoV-2 detection performed in an automated workflow](https://www.medrxiv.org/content/10.1101/2020.03.07.20032326v1)

[Combination of RT‐qPCR testing and clinical features for diagnosis of COVID‐19 facilitates management of SARS‐CoV‐2 outbreak](https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25721)

[Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens](https://www.medrxiv.org/content/10.1101/2020.04.17.20069864v1)

[Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes](https://www.biorxiv.org/content/10.1101/2020.04.17.047118v1)

[Comparison of SARS-CoV2 N gene real-time RT-PCR targets and commercially available mastermixes](https://www.biorxiv.org/content/10.1101/2020.04.17.047118v1)

[COVID-19 Protocolo - Grupo de investigación Neuronal Ubiquitin Pathways - UPV/EHU](https://www.ehu.eus/es/web/umayor/covid-19-protocol)

[CRISPR–Cas12-based detection of SARS-CoV-2](https://www.nature.com/articles/s41587-020-0513-4)

[Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR](https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045) 

[Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19)](http://www.en-journal.org/journal/view.html?doi=10.5607/en20009)

[Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA](https://www.medrxiv.org/content/10.1101/2020.04.18.20070755v1)

[Detection of Respiratory Viruses in Sputum from Adults by Use of Automated Multiplex PCR](https://jcm.asm.org/content/52/10/3590.long)

[Developing antibody tests for SARS-CoV-2](https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30788-1/fulltext)

[DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION STEP](https://www.biorxiv.org/content/10.1101/2020.03.20.001008v2)

[Efficient and Practical Sample Pooling High-Throughput PCR Diagnosis of COVID-19](https://www.medrxiv.org/content/10.1101/2020.04.06.20052159v1)

[Estimating false-negative detection rate of SARS-CoV-2 by RT-PCR](https://www.medrxiv.org/content/10.1101/2020.04.05.20053355v1)

[Evaluation of Reverse Transcription-PCR Assays for Rapid Diagnosis of Severe Acute Respiratory Syndrome Associated with a Novel Coronavirus](https://jcm.asm.org/content/41/10/4521)

[Evaluation of WHO listed COVID-19 qPCR primers and probe in silico with 375 SERS-CoV-2 full genome sequences](https://www.medrxiv.org/content/10.1101/2020.04.22.20075697v1)

[FALSE-NEGATIVE RESULTS OF INITIAL RT-PCR ASSAYS FOR COVID-19: A SYSTEMATIC REVIEW](https://www.medrxiv.org/content/10.1101/2020.04.16.20066787v1)

[Fast SARS-CoV-2 detection by RT-qPCR in preheated nasopharyngeal swab samples](https://www.medrxiv.org/content/10.1101/2020.04.08.20058495v1)

[Fast SARS-CoV-2 detection protocol based on RNA precipitation and RT-qPCR in nasopharyngeal swab samples](https://www.medrxiv.org/content/10.1101/2020.04.26.20081307v1)

[High-throughput extraction of SARS-CoV-2 RNA from nasopharyngeal swabs using solid-phase reverse immobilization beads](https://www.medrxiv.org/content/10.1101/2020.04.08.20055731v1)

[Increased PCR screening capacity using a multi-replicate pooling scheme](https://www.medrxiv.org/content/10.1101/2020.04.16.20067603v1)

[In silico analysis of RT-qPCR designs recommended by WHO for detection of SARS-CoV-2 and a commercial kit validated following UNE/EN ISO 17025:2005 and two reference laboratories](https://www.biorxiv.org/content/10.1101/2020.04.27.065383v1)

[Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic](https://www.medrxiv.org/content/10.1101/2020.04.29.20085514v1)

[Molecular Detection of SARS-CoV-2 in Formalin Fixed Paraffin Embedded Specimens](https://www.biorxiv.org/content/10.1101/2020.04.21.042911v1)

[Non-specific Primers Reveal False-negative Risk in Detection of COVID-19 Infections](https://www.medrxiv.org/content/10.1101/2020.04.07.20056804v1)

[Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction](biorxiv.org/cgi/content/short/2020.04.06.028902)

[Overcoming the bottleneck to widespread testing: A rapid review of nucleid acid testing approaches for COVID-19 detection](https://gitlab.com/tjian-darzacq-lab/covid19_review/-/blob/master/COVID19_review_V7.pdf)

[Pooled RNA extraction and PCR assay for efficient SARS-CoV-2 detection](https://www.medrxiv.org/content/10.1101/2020.04.17.20069062v1)

[Pooled RNA sample reverse transcriptase real time PCR assay for SARS CoV-2 infection: a reliable, faster and economical method](https://www.medrxiv.org/content/10.1101/2020.04.25.20079095v1)

[Portable and accurate diagnostics for COVID-19: Combined use of the miniPCR thermocycler and a well-plate reader for SARS-Co2 virus detection](https://www.medrxiv.org/content/10.1101/2020.04.03.20052860v1)

[Positive RT-PCR Test Results in Patients Recovered From COVID-19](https://jamanetwork.com/journals/jama/fullarticle/2762452) 

[Preliminary support for a 'dry swab, extraction free' protocol for SARS-CoV-2 testing via RT-qPCR](https://www.biorxiv.org/content/10.1101/2020.04.22.056283v1)

[Rapid and quantitative detection of COVID-19 markers in micro-liter sized samples](https://www.biorxiv.org/content/10.1101/2020.04.20.052233v1)

[Rapid colorimetric detection of COVID-19 coronavirus using a reverse tran-scriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic plat-form: iLACO](https://www.medrxiv.org/content/10.1101/2020.02.20.20025874v1)

[Rapid diagnosis of SARS-CoV-2 infection by detecting IgG and IgM antibodies with an immunochromatographic device: a prospective single-center study](https://www.medrxiv.org/content/10.1101/2020.04.11.20062158v1)

[Rapid direct nucleic acid amplification test without RNA extraction for SARS-CoV-2 using a portable PCR thermocycler](https://www.biorxiv.org/content/10.1101/2020.04.17.042366v1)

[Rapid Molecular Detection of SARS-CoV-2 (COVID-19) Virus RNA Using Colorimetric LAMP](https://www.medrxiv.org/content/10.1101/2020.02.26.20028373v1)

[Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19](https://www.medrxiv.org/content/10.1101/2020.04.24.20078949v1)

[Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19](https://mbio.asm.org/content/11/2/e00722-20)

[Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation](https://www.medrxiv.org/content/10.1101/2020.04.22.20074351v1)

[Reverse-transcription quantitative PCR directly from cells without RNA extraction and without isothermal reverse-transcription: a ‘zero-step’ RT-qPCR protocol](https://academic.oup.com/biomethods/article/2/1/bpx008/3858804)

[RT-qPCR detection of SARS-CoV-2 RNA from patient nasopharyngeal swab using Qiagen RNEasy kits or directly via omission of an extraction step](https://www.biorxiv.org/content/10.1101/2020.03.20.001008v1) 

[Saliva Sample as a Non-Invasive Specimen for the Diagnosis of Coronavirus Disease-2019 (COVID-19): a Cross-Sectional Study](https://www.medrxiv.org/content/10.1101/2020.04.17.20070045v1)

[Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs](https://www.medrxiv.org/content/10.1101/2020.04.16.20067835v1)

[SARS-CoV-2 detection with CRISPR diagnostics](https://www.biorxiv.org/content/10.1101/2020.04.10.023358v1)

[SARS-CoV-2 Detection Using an Isothermal Amplification Reaction and a Rapid, Inexpensive Protocol for Sample Inactivation and Purification](https://www.medrxiv.org/content/10.1101/2020.04.23.20076877v1)[Smart Pooled sample Testing for COVID-19: A Possible Solution for Sparsity of Test Kits](https://www.medrxiv.org/content/10.1101/2020.04.21.20044594v1)

[Sequential informed pooling approach to detect SARS-CoV2 infection](https://www.medrxiv.org/content/10.1101/2020.04.24.20077966v1)

[The Potential Use of Unprocessed Sample for RT-qPCR Detection of COVID-19 without an RNA Extraction Step](https://www.biorxiv.org/content/10.1101/2020.04.06.028811v1)

[Variation in False Negative Rate of RT-PCR Based SARS-CoV-2 Tests by Time Since Exposure](https://www.medrxiv.org/content/10.1101/2020.04.07.20051474v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Sciencific Data and Resources"></a>
## Sciencific Data and Resources ##

[2019 Novel Coronavirus COVID-19 (2019-nCoV) Data Repository by Johns Hopkins CSSE](https://github.com/CSSEGISandData/COVID-19)
<p align="center">
  <a href="https://github.com/CSSEGISandData/COVID-19" title="See this resource">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/JHU-CSSE_dashboard.png" width="40%" />
  </a>
</p>


[Análisis de los datos de COVID-19 en España, por Z Data Labs](https://zzdatalabs.com/coronavirus-es/)
<p align="center">
    <a href="https://zzdatalabs.com/coronavirus-es/" title="See this resource">
      <img src="https://zzdatalabs.com/wp-content/uploads/2019/07/Extended_headerAsset-21.png" width="40%"/>
    </a> 
</p>


[Artic Network](https://artic.network/ncov-2019)
<p align="center">
    <a href="https://artic.network/ncov-2019" title="See this resource">
      <img src="https://artic.network/assets/images/artic-logo-sticker.png" width="10%" />
    </a> 
</p>

[Bioinformatics Unit of Instituto de Salud Carlos III (Spain)](https://github.com/BU-ISCIII/SARS-Cov2_analysis) 

<p align="center">
    <a href="https://github.com/BU-ISCIII/SARS-Cov2_analysis" title="See this resource">
      <img src="https://github.com/BU-ISCIII/SARS-Cov2_analysis/blob/master/BU_ISCIII_logo.png" width="30%"/>
    </a> 
</p>

[Bioinformatics resources for SARS-CoV-2](http://www.clinbioinfosspa.es/CovidResources) 

[Broad COVID-19 Testing Dashboard](https://covid19-testing.broadinstitute.org/)

[CIVIO datos Pruebas PCR para detectar casos de coronavirus. Actualización diaria con el número (total y relativo) de PCR realizadas por comunidades autónomas para diagnosticar casos de covid-19](https://datos.civio.es/dataset/pcr-coronavirus-covid19-espana-comunidades-autonomas/)

[Clustering COVID-19 research papers](https://gclen.github.io/covid19-kaggle/plots/umap_covid-19_interactive.html)

[COG-UK The New Microreact dashboard](https://microreact.org/project/COGconsortium)
<p align="center">
    <a href="https://www.covidvisualizer.com/" title="See this resource">
      <img src="https://www.cogconsortium.uk/wp-content/themes/cogconsortium/dist/assets/svg/logos/logo-cog-uk.png" width="30%"/>
    </a> 
</p>

[Coronavirus analysis tools developed by scientists at the University of Tartu, Estonia](https://koroona.ut.ee/?lang=en)

[Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)](https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6)

[COVID-19 Collaboration Platform](https://covidcp.org/)

[COVID-19 Data Hub. Funded by the Institute for Data Valorization IVADO, Canada](https://covid19datahub.io/)

[Coronavirus Structural Task Force](https://github.com/thorn-lab/coronavirus_structural_task_force)

[COVID-19 3D visualizer](https://www.covidvisualizer.com/)
<p align="center">
    <a href="https://www.covidvisualizer.com/" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/covidvisualizer.com.png" width="30%"/>
    </a> 
</p>

[COVID-19 Data Portal](https://www.covid19dataportal.org/)

[COVID-19 Host Genetics Initiative](https://www.covid19hg.org/)

[COVID-19:on average only 6% of actual SARS-CoV-2 infections detected worldwide, University of Göttingen](http://www.uni-goettingen.de/de/document/download/3d655c689badb262c2aac8a16385bf74.pdf/Bommer%20&%20Vollmer%20(2020)%20COVID-19%20detection%20April%202nd.pdf)

[COVID-19 Open Research Dataset Challenge (CORD-19)](https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge) 
<p align="center">
    <a href="https://www.kaggle.com/allen-institute-for-ai/CORD-19-research-challenge" title="See this resource">
      <img src="https://www.kaggle.com/static/images/site-logo.png" width="20%"/>
    </a> 
</p>

[COVID-19 scenarios](https://neherlab.org/covid19/) 

[CDC Morbidity and Mortality Weekly Report (MMWR) Novel Coronavirus Reports](https://www.cdc.gov/mmwr/Novel_Coronavirus_Reports.html) 

[COVID-19 R-shiny codes](https://github.com/topics/covid-19) 

[CDC Information for Laboratories RT-PCR resources](https://www.cdc.gov/coronavirus/2019-ncov/lab/index.html) 

[COVID-19 Tracker Shiny app in R](https://mentalbreaks.shinyapps.io/covid19/)

[CSVS Babelomics Collaborative Spanish Variant Server to visualize polimorphisms in the Spanish population in genes related with COVIDー19](https://twitter.com/CSVS_es/status/1244286199243603972)

[DataStudio International-Domestic spreading of 2019-nCoV-V4](https://datastudio.google.com/reporting/3ffd36c3-0272-4510-a140-39e288a9f15c/page/U5lCB)
<p align="center">
    <a href="https://datastudio.google.com/reporting/3ffd36c3-0272-4510-a140-39e288a9f15c/page/U5lC" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/International_Domestic_SpreadingCOVID-19.png" width="30%"/>
    </a> 
</p>

[Databriks data collection](https://databricks.com/blog/2020/04/14/covid-19-datasets-now-available-on-databricks.html)

[Datadista data on COVID-19](https://github.com/datadista/datasets/blob/master/COVID%2019/readme.md)

[Dashboard del Sistema para la Vigilancia de la mortalidad diaria por todas las causas en España (Informe MoMo)](https://momo.isciii.es/public/momo/dashboard/momo_dashboard.html)
<p align="center">
    <a target="_blank" href="https://momo.isciii.es/public/momo/dashboard/momo_dashboard.html" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/MoMo-dashboard.png" width="30%"/>
    </a> 
</p>

[Discourse Data Against Covid19](https://discourse.data-against-covid.org/)

[GISAID](https://www.gisaid.org/)
<p align="center">
    <a href="https://www.gisaid.org/" title="See this resource">
      <img src="https://www.gisaid.org/fileadmin/gisaid/img/schild.png" width="20%"/>
    </a> 
</p>

[EMBL-EBI COVID-19 Portal](https://www.ebi.ac.uk/covid-19)
<p align="center">
    <a href="https://www.ebi.ac.uk/covid-19" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/EMBL-EBI-COVID19.png" width="30%"/>
    </a> 
</p>

[Epidemic Calculator](http://gabgoh.github.io/COVID/index.html) 
<p align="center">
    <a href="http://gabgoh.github.io/COVID/index.html" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/epidemic_calculator.png" width="30%"/>
    </a> 
</p>

[ETE team modeling group ( MIVEGEC Laboratory , CNRS, IRD, University of Montpellier)](http://bioinfo-shiny.ird.fr:3838/COVIDSIM/)

[European mortality monitoring: EUROMOMO](https://www.euromomo.eu/graphs-and-maps)

[European Centre for Disease Prevention and Control](https://data.europa.eu/euodp/en/data/dataset/covid-19-coronavirus-data)
[European Centre for Disease Prevention and Control, data](https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide)
<p align="center">
    <a href="https://www.ecdc.europa.eu/en/publications-data/download-todays-data-geographic-distribution-covid-19-cases-worldwide" title="See this resource">
      <img src="https://data.europa.eu/euodp/sites/all/themes/openDataPortalTheme/images/odp_en.png" width="40%"/>
    </a> 
</p>

[European Data Portal, data for Spain, Evolución de enfermedad por el coronavirus (COVID-19)](https://www.europeandataportal.eu/data/datasets?locale=en&query=covid%20&page=1&country=es)
<p align="center">
    <a href="https://www.europeandataportal.eu/data/datasets?locale=en&query=covid%20&page=1&country=es" title="See this resource">
      <img src="https://data.europa.eu/euodp/sites/all/themes/openDataPortalTheme/images/odp_en.png" width="40%"/>
    </a> 
</p>

[Evolución del coronavirus (COVID-19) en Euskadi](https://opendata.euskadi.eus/catalogo/-/evolucion-del-coronavirus-covid-19-en-euskadi/) 
<p align="center">
    <a href="https://opendata.euskadi.eus/catalogo/-/evolucion-del-coronavirus-covid-19-en-euskadi/" title="See this resource">
      <img src="https://opendata.euskadi.eus/images/w79-logo_opendata.gif" width="30%"/>
    </a> 
</p>

[Explore the Spread of Covid-19, Humboldt-Universität zu Berlin](https://trr266.wiwi.hu-berlin.de/shiny/tidycovid19/)

[How many tests for COVID-19 are being performed around the world?](https://ourworldindata.org/covid-testing) 

[IHME, Institute for Health Metrics and Evaluation, USA data](https://covid19.healthdata.org/projections?sfns=mo)
<p align="center">
    <a href="https://covid19.healthdata.org/projections?sfns=mo" title="See this resource">
      <img src="https://covid19.healthdata.org/dist/images/ihme-logo.svg" width="30%"/>
    </a> 
</p>

[Imperial College London reports](https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/) 

[Informes MoMo (Sistema de Monitorización de la Mortalidad Diaria (Sistema MoMo) del Instituto de Salud Carlos III](https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/MoMo/Paginas/Informes-MoMo-2020.aspx)
<p align="center">
    <a href="https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/MoMo/Paginas/Informes-MoMo-2020.aspx" title="See this resource">
      <img src="https://www.isciii.es/Style%20Library/ISCIII.Portal/imagenes/LogoISCIII.svg" width="40%"/>
    </a> 
</p>

[Instituto de Matemática Interdisciplinar de la Universitat Politécnica de Valencia (UPV) Modelling Uncertainty Quantification, Reports in PDF](https://www.imm.upv.es/covid-19/) [Modelización epidemiolgica: Informes](https://covid19.webs.upv.es/informes.html)

<p align="center">
    <a href="https://www.imm.upv.es/covid-19/" title="See this resource">
      <img src="http://covid19.webs.upv.es/IMAGENES/prueba3.png" width="50%"/>
    </a> 
</p>

[Jupyter R notebook for prediction modelling of Covid-19 data. Predictive modelling of 2019-nCov outbreak data in Canary Islands. Departamento de Matemáticas, Estadística e Investigación Operativa, ULL](https://github.com/ULL-STAT/covid19_model)
<p align="center">
    <a href="https://github.com/ULL-STAT/covid19_model" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/COVID-19_ULL.png" width="30%"/>
    </a> 
</p>

[MIDAS 2019 Novel Coronavirus Repository](https://github.com/midas-network/COVID-19)
<p align="center">
    <a target="_blank" href="https://github.com/midas-network/COVID-19" title="See this resource">
      <img src="https://raw.githubusercontent.com/midas-network/COVID-19/master/docs/MIDAS-4.png" width="20%"/>
    </a> 
</p>

[Ministerio de Sanidad, España](https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.html)
<br>
<p align="center">
    <a href="https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/home.html" title="See this resource">
      <img src="https://www.mscbs.gob.es/diseno/img/BANER-CORONAVIRUS-900X100.jpg" width="60%"/>
    </a> 
</p>

[National Genomics Data Center, Beijing Institute of Genomics, Chinese Academy of Sciences](https://bigd.big.ac.cn/ncov/v2?lang=en) [Released genomes](https://bigd.big.ac.cn/ncov/release_genome)
<p align="center">
    <a href="https://bigd.big.ac.cn/ncov/v2?lang=en" title="See this resource">
      <img src="https://bigd.big.ac.cn/static/image/nsti.png" width="20%"/>
    </a> 
</p>

[NCBI SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) Sequences](https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/)

[NIH Coronavirus Disease 2019 Situation Summary](https://www.nih.gov/health-information/coronavirus) 
<p align="center">
    <a href="https://www.nih.gov/health-information/coronavirus" title="See this resource">
      <img src="https://www.nih.gov/sites/all/themes/nih/images/nih-logo-color.png" width="30%"/>
    </a> 
</p>

[Nanopore (ONT) Novel Coronavirus information(COVID-19)](https://nanoporetech.com/about-us/news/novel-coronavirus-covid-19-information-and-updates)
<p align="center">
    <a href="https://nanoporetech.com/about-us/news/novel-coronavirus-covid-19-information-and-updates" title="See this resource">
      <img src="https://nanoporetech.com/themes/custom/nanopore/images/ont-logo.svg" width="40%"/>
    </a> 
</p>

[Nextstrain. Real-time tracking of pathogen evolution](https://nextstrain.org/)
<p align="center">
  <a href="https://nextstrain.org/" title="See this resource">
    <img src="https://nextstrain.org/dist/ea8c3e13e8c17436264760d638ab970e.png" width="10%" />
  </a>
</p>

[PolyMath COVID-19 dataset clearinghouse](http://michaelnielsen.org/polymath1/index.php?title=COVID-19_dataset_clearinghouse)

[SARS-CoV-2 Galaxy Project](https://github.com/galaxyproject/SARS-CoV-2) 
<p align="center">
    <a href="https://github.com/galaxyproject/SARS-CoV-2" title="See this resource">
      <img src="https://raw.githubusercontent.com/galaxyproject/SARS-CoV-2/master/genomics/img/galaxy_logo.png" width="20%"/>
    </a> 
</p>

[SARS-CoV-2 pathways](https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways) 
<p align="center">
    <a href="https://www.wikipathways.org/index.php/Portal:Disease/COVIDPathways" title="See this resource">
      <img src="https://www.wikipathways.org//skins/common/images/wplogo_125.png" width="20%"/>
    </a> 
</p>

[SARS-CoV-2 Sequencing Resources](https://github.com/CDCgov/SARS-CoV-2_Sequencing) 

[SWISSMODEL homology models](http://www.rcsb.org/news?year=2020&article=5e3c4bcba5007a04a313edcc)

[The COVID Tracking Project, testing data available for US states and territories](https://covidtracking.com/)

[Virological](http://virological.org/)
<p align="center">
    <a href="http://virological.org/" title="See this resource">
      <img src="http://virological.org/uploads/default/original/1X/7897c4e655617c4b6fe71a98eaa97a38778f0623.png" width="20%"/>
    </a> 
</p>

[Uniform analysis of coronavirus and SARS-COV-2 nanopore direct RNA sequencing datasets using MasterOfPores](https://biocorecrg.github.io/covid/)

[United Against COVID-19](http://united-against-covid.org/)

[WHO updates COVID-19 dashboard with better data visualization](https://covid19.who.int/)

[World-o-Meter](https://www.worldometers.info/coronavirus/) 
<p align="center">
    <a href="https://www.worldometers.info/coronavirus/" title="See this resource">
      <img src="https://www.worldometers.info/img/worldometers-logo.gif" width="30%"/>
    </a> 
</p>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>



<!-- ------------------ SUB-SECTION ------------------ -->
<a name="Autonomous Regions and Cities in Spain"></a>
> List of institutional websites for the governments of each of the Spanish Autonomous Regions (17) and Cities (2).

Autonomous Regions and Cities in Spain:
<ul>

<li>
<a href="https://www.aragon.es/coronavirus" title="See this resource">Aragón</a>
</li>

<li>
<a href="https://www.asturias.es/portal/site/webasturias/menuitem.4b280f8214549ead3e2d6f77f2300030/?vgnextoid=bae12eee144c0710VgnVCM10000097030a0aRCRD&vgnextchannel=d682d22a18b6e210VgnVCM1000002f030003RCRD&i18n.http.lang=es" title="See this resource">Principado de Asturias</a>
</li>

<li>
<a href="https://sanidad.castillalamancha.es/ciudadanos/enfermedades-infecciosas/coronavirus" title="See this resource">Castilla La Mancha</a>
<a href="https://sanidad.castillalamancha.es/ciudadanos/enfermedades-infecciosas/coronavirus/actualizacion-de-casos-en-castilla-la-mancha" title="See this resource">Datos</a>
</li>

<li>
  <a href="https://www.gobiernodecanarias.org/sanidad/scs/covid19" title="See this resource">Portal del GOBCAN con el seguimiento de la pandemia por SARS-Cov-2</a>
  <a href="https://www3.gobiernodecanarias.org/sanidad/scs/content/dcb400c5-6504-11ea-9a8e-719d4b52bf6c/InformeCasosCOVID-19.pdf" title="See this resource">Canarias. Informes epidemiológicos de Salud Pública de la Consejería de Sanidad del Gobierno Autónomo de Canarias</a>
  <a href="https://grafcan1.maps.arcgis.com/apps/opsdashboard/index.html#/156eddd4d6fa4ff1987468d1fd70efb6" >Dashboard with graphical information on COVID-19 incidence in the Canary Islands, by Grafcan-GOBCAN</a>
</li>

<li>
<a href="https://www.aspb.cat/documents/covid19-cast/" title="See this resource">Generalitat de Catalunya</a>
<a href="http://aquas.gencat.cat/ca/actualitat/ultimes-dades-coronavirus" title="See this resource">Datos</a>
</li>

<li>
<a href="http://saludcantabria.es/index.php?mact=News,cntnt01,detail,0&cntnt01articleid=2145&cntnt01origid=15&cntnt01returnid=289" title="See this resource">Cantabria</a>
</li>

<li>
<a href="https://www.ceuta.es/ceuta/index.php" title="See this resource">Ciudad Autónoma de Ceuta</a>
</li>

<li>
<a href="http://www.caib.es/sites/coronavirus/es/portada/" title="See this resource">Govern Illes Balears</a>
</li>

<li>
<a href="https://www.juntadeandalucia.es/organismos/saludyfamilias/areas/salud-vida/paginas/Nuevo_Coronavirus.html" title="See this resource">Junta de Andalucía</a>
</li>

<li>
<a href="http://www.juntaex.es/web/" title="See this resource">Junta de Extremadura</a>
</li>

<li>
<a href="https://coronavirus.sergas.gal/" title="See this resource">Xunta de Galicia</a>
</li>

<li>
<a href="https://analisis.datosabiertos.jcyl.es/pages/coronavirus/situacin-actual#situacin-actual" title="See this resource">Junta de Castilla y León. Situación epidemiológica del coronavirus en Castilla y León — Análisis de datos abiertos JCyL</a>
</li>

<li>
<a href="https://www.comunidad.madrid/servicios/salud/2019-nuevo-coronavirus" title="See this resource">Madrid</a> | <a href="https://datos.comunidad.madrid/catalogo/dataset/covid19_tia_zonas_basicas_salud" >Covid 19 -TIA Zonas Básicas de Salud - Conjuntos de datos - Datos Abiertos Comunidad de Madrid</a>
</li>

<li>
<a href="https://www.melilla.es/melillaPortal/index.jsp" title="See this resource">Ciudad Autónoma de Melilla</a>
</li>

<li>
<a href="https://www.navarra.es/es/web/coronavirus/inicio" title="See this resource">Navarra</a>
<a href="https://www.navarra.es/es/web/coronavirus/situacion-actua" title="See this resource">Datos</a>
</li>

<li>
<a href="https://www.osakidetza.euskadi.eus/inicio/" title="See this resource">País Vasco</a>
</li>

<li>
<a href="http://www.carm.es/web/pagina?IDCONTENIDO=106861&IDTIPO=10&RASTRO=c$m122,70" title="See this resource">Región de Murcia</a>
</li>

<li>
<a href="https://web.larioja.org/" title="See this resource">La Rioja</a>
</i>

<li>
<a href="http://infocoronavirus.gva.es/" title="See this resource">Generalitat Valenciana</a>
</li>

</ul>

[Casos de Covid-19 en España por Comunidades Autónomas, by CJP](https://public.flourish.studio/visualisation/1693192/)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Seroprevalence"></a>
## Seroprevalence ##
> New section on April 26, 2020.

[A serological assay to detect SARS-CoV-2 seroconversion in humans](https://www.medrxiv.org/content/10.1101/2020.03.17.20037713v2)

[A Statistical Analysis Of CoV-19 Positive Test Frequency Data Indicates A Need For Greater Attention To CoV-19 Test Quality And Pre-Wuhan Cov-19 Prevalence](https://www.medrxiv.org/content/10.1101/2020.04.24.20078402v1)

[COVID-19 Antibody Seroprevalence in Santa Clara County, California](https://www.medrxiv.org/content/10.1101/2020.04.14.20062463v1)

[Estimating COVID-19 Antibody Seroprevalence in Santa Clara County, California. A re-analysis of Bendavid et al.](https://www.medrxiv.org/content/10.1101/2020.04.24.20078824v1)

[Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors](https://www.medrxiv.org/content/10.1101/2020.04.24.20075291v1)

[Estimating population immunity without serological testing](https://www.medrxiv.org/content/10.1101/2020.04.23.20076786v1)

[Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence Testing in Idaho](https://www.medrxiv.org/content/10.1101/2020.04.27.20082362v1)

[Presence of SARS-CoV-2 reactive T cells in COVID-19 patients and healthy donors](https://www.medrxiv.org/content/10.1101/2020.04.17.20061440v1)

[SARS‐CoV‐2 Seroconversion in Humans: A Detailed Protocol for a Serological Assay, Antigen Production, and Test Setup](https://currentprotocols.onlinelibrary.wiley.com/doi/full/10.1002/cpmc.100)

[Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital](https://www.medrxiv.org/content/10.1101/2020.04.27.20082289v1)

[Test performance evaluation of SARS-CoV-2 serological assays](https://www.medrxiv.org/content/10.1101/2020.04.25.20074856v1)

[The potential danger of suboptimal antibody responses in COVID-19](https://www.nature.com/articles/s41577-020-0321-6)

[Towards the next phase: evaluation of serological assays for diagnostics and exposure assessment](https://www.medrxiv.org/content/10.1101/2020.04.23.20077156v1)


<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>




<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Sequencing, Sequences and Bioinformatics"></a>
## Sequencing, Sequences and Bioinformatics ##
> A section of sequencing protocols, sequence sources and related bioinformatics pipelines

[A High-Coverage SARS-CoV-2 Genome Sequence Acquired by Target Capture Sequencing](https://www.medrxiv.org/content/10.1101/2020.04.11.20061507v1)

[Alternative Illumina protocol for SARS sequencing (for Ct up to 38)](https://www.protocols.io/view/rtpcr-amplification-of-sars-cov2-whole-genome-for-bew8jfhw)

[Broad Institute viral-related pipelines. Several available repositories with scripts and tools for the analysis of viral NGS data](https://github.com/broadinstitute?q=vir&type=&language=)

[Centre for Genomic Regulation, CRG, public.docs repository, COVID sequences, including fast5 files](https://public-docs.crg.es/covid/)
<p align="center">
    <a href="https://public-docs.crg.es/covid/" title="See this resource">
      <img src="https://public-docs.crg.es/icons/logo-crg.png" width="30%"/>
    </a> 
</p>

[Characterization of intra-host SARS-CoV-2 variants improves phylogenomics reconstruction and may reveal functionally convergent mutations](https://www.biorxiv.org/content/10.1101/2020.04.22.044404v1)

[China National Center for Bioinformation (CNCB), 2019 Novel Coronavirus Resource](https://bigd.big.ac.cn/ncov/?lang=en)     |     [Genome Variation](https://bigd.big.ac.cn/ncov/variation)     |     [Data release statistics](https://bigd.big.ac.cn/ncov/release_genome)
<p align="center">
    <a href="https://bigd.big.ac.cn/ncov/?lang=en" title="See this resource">
      <img src="https://bigd.big.ac.cn/ncov/static/image/ncovr-logo.png" width="25%"/>
    </a> 
</p>

[CDC GitHub SARS-CoV-2 Sequencing Resources](https://github.com/CDCgov/SARS-CoV-2_Sequencing/blob/master/README.md)

[CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic](https://www.biorxiv.org/content/10.1101/2020.04.10.036343v1)
<p align="center">
    <a href="https://www.biorxiv.org/content/10.1101/2020.04.10.036343v1" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CoV-Genome-Tracker.png" width="30%"/>
    </a> 
</p>

[COVID-19 ARTIC v3 Illumina library construction and sequencing protocol](https://www.protocols.io/view/covid-19-artic-v3-illumina-library-construction-an-beuzjex6)

[COVID-19 Cell Atlas](https://www.covid19cellatlas.org/)

[Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility](https://journals.physiology.org/doi/full/10.1152/physrev.00013.2020)

[Emergence of multiple variants of SARS-CoV-2 with signature structural changes](https://www.biorxiv.org/content/10.1101/2020.04.26.062471v1)

[Enrichment workflow for detecting coronavirus using Illumina NGS systems](https://www.illumina.com/content/dam/illumina-marketing/documents/products/appnotes/ngs-enrichment-coronavirus-app-note-1270-2020-002.pdf)

[How fast does the SARS-Cov-2 virus really mutate in heterogeneous populations?](https://www.medrxiv.org/content/10.1101/2020.04.23.20076075v1)

[Katarina Braun GitHub ARS-CoV-2_sequencing repository](https://github.com/katarinabraun/SARS-CoV-2_sequencing)

[NCBI GenBank SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) Sequences](https://www.ncbi.nlm.nih.gov/genbank/sars-cov-2-seqs/)

[NCBI GenBank Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome. GenBank: MN908947.3](https://www.ncbi.nlm.nih.gov/nuccore/MN908947)
<p align="center">
    <a href="https://www.ncbi.nlm.nih.gov/nuccore/MN908947" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/MN908947.3.png" width="40%"/>
    </a> 
</p>

[Quality control of low-frequency variants in SARS-CoV-2 genomes](https://www.biorxiv.org/content/10.1101/2020.04.26.062422v1)

[SARS coronavirus 2 in Viral Zone / Covid-19 genome expression](https://viralzone.expasy.org/9076)

[The global population of SARS-CoV-2 is composed of six major subtypes](https://www.biorxiv.org/content/10.1101/2020.04.14.040782v1)

[Specific mutations in SARS-CoV2 RNA dependent RNA polymerase and helicase alter protein structure, dynamics and thus function: Effect on viral RNA replication](https://www.biorxiv.org/content/10.1101/2020.04.26.063024v1)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Shiny and R related dashboards and packages"></a>
## Shiny and R related dashboards and packages ##
> Section to show relevant Shiny dashborads, R packages and codes. Under construction...
 
<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>


<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Viral mechanisms and Tropism"></a>
## Viral mechanisms and Tropism: infection, entry, and replication ##
> Section to describe the different mechanisms and tropism that the virus displays. Under construction...

[A gene locus that controls expression of ACE2 in virus infection](https://www.medrxiv.org/content/10.1101/2020.04.26.20080408v1)

[Another Decade, Another Coronavirus](https://www.nejm.org/doi/full/10.1056/NEJMe2001126)

[A single-cell atlas of the peripheral immune response to severe COVID-19](https://www.medrxiv.org/content/10.1101/2020.04.17.20069930v1)

[ACE2 and TMPRSS2 variants and expression as candidates to sex and country differences in COVID-19 severity in Italy](https://www.medrxiv.org/content/10.1101/2020.03.30.20047878v2)

[ACE2: from vasopeptidase to SARS virus receptor](https://linkinghub.elsevier.com/retrieve/pii/S0165-6147(04)00097-5)

[ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia](http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=16282461)

[ACE2 shedding and furin abundance in target organs may influence the efficiency of SARS-CoV-2 entry](http://www.chinaxiv.org/abs/202002.00082)

[A highly conserved cryptic epitope in the receptor-binding domains of SARS-CoV-2 and SARS-CoV](https://science.sciencemag.org/content/early/2020/04/02/science.abb7269)

[Analysis the susceptibility of lung cancer patients to SARS-CoV-2 infection](https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3558022)

[Angiotensin‐converting enzyme 2 (ACE2) as a SARS‐CoV‐2 receptor: molecular mechanisms and potential therapeutic target](https://link.springer.com/article/10.1007/s00134-020-05985-9)

[Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus](https://www.nature.com/articles/nature02145)

[Angiotensin Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.120.317015)

[Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics](https://onlinelibrary.wiley.com/doi/full/10.1002/ddr.21656)

[A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin](https://www.ncbi.nlm.nih.gov/pubmed/32274964)

[A Unique Protease Cleavage Site Predicted in the Spike Protein of the Novel Pneumonia Coronavirus (2019-nCoV) Potentially Related to Viral Transmissibility](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091172/)

[Bioinformatics Study on Structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) For Better Understanding the Vaccine Development](https://www.biorxiv.org/content/10.1101/2020.04.21.053199v2)

[CD147/EMMPRIN Acts as a Functional Entry Receptor for Measles Virus on Epithelial Cells](https://jvi.asm.org/content/84/9/4183.long)

[Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations](https://www.biorxiv.org/content/10.1101/2020.04.22.044404v1)


[Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site](https://www.biorxiv.org/content/10.1101/2020.03.22.002204v1)

[Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV](https://www.nature.com/articles/s41467-020-15562-9)

[Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine](https://www.nature.com/articles/s41423-020-0400-4)

[We shouldn’t worry when a virus mutates during disease outbreaks](https://www.nature.com/articles/s41564-020-0690-4)

[Comparative computational analysis of SARS-CoV-2 nucleocapsid protein epitopes in taxonomically related coronaviruses](https://www.sciencedirect.com/science/article/pii/S1286457920300538)

[Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories](https://www.medrxiv.org/content/10.1101/2020.04.24.20074559v1)

[Complement as a target in COVID-19?](https://www.nature.com/articles/s41577-020-0320-7)

[Coronavirus envelope protein: current knowledge](https://virologyj.biomedcentral.com/articles/10.1186/s12985-019-1182-0)

[Coronavirus infections and immune responses](https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25685)

[COVID‐19 in the heart and the lungs: could we “Notch” the inflammatory storm?](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144545/)

[COVID-19. Transport of respiratory droplets in a microclimatologic urban scenario](https://www.medrxiv.org/content/10.1101/2020.04.17.20064394v1)

[Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation](https://science.sciencemag.org/content/367/6483/1260)

[Cyclophilin–CD147 interactions: a new target for anti-inflammatory therapeutics](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883100/)

[Elevated Plasmin(ogen) as a Common Risk Factor for COVID-19 Susceptibility](https://journals.physiology.org/doi/full/10.1152/physrev.00013.2020)

[Elucidating the differences in the molecular mechanism of receptor binding between 2019-nCoV and the SARS-CoV viruses using computational tools](https://www.biorxiv.org/content/10.1101/2020.04.21.053009v1)

[Emerging WuHan (COVID-19) coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26](https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1739565)

[Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells](https://www.pnas.org/content/117/13/7001)

[Evolutionary stasis of viruses?](https://www.nature.com/articles/s41579-019-0168-7)

[Reply to ‘Evolutionary stasis of viruses?’](https://www.nature.com/articles/s41579-019-0169-6)

[Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys](https://www.medrxiv.org/content/10.1101/2020.04.15.20067066v1)

[Evaluation of antibody testing for SARS-Cov-2 using ELISA and lateral flow immunoassays](https://www.medrxiv.org/content/10.1101/2020.04.15.20066407v1)

[Expression of SARS-CoV-2 receptor ACE2 and the spike protein processing enzymes in developing human embryos](https://arxiv.org/abs/2004.04935)

[Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event](https://www.sciencedirect.com/science/article/pii/S1567134820300447)

[Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses](https://www.nature.com/articles/s41564-020-0688-y)

[Host, Viral, and Environmental Transcriptome Profiles of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)](https://www.biorxiv.org/content/10.1101/2020.04.20.048066v4)

[Human ACE2 receptor polymorphisms predict SARS-CoV-2 susceptibility](https://www.biorxiv.org/content/10.1101/2020.04.07.024752v1)

[Individual variation of the SARS-CoV2 receptor ACE2 gene expression and regulation](https://www.preprints.org/manuscript/202003.0191/v1)

[Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro](https://www.biorxiv.org/content/10.1101/2020.04.07.029884v1)

[Integrated analyses of single-cell atlases reveal age, gender, and smoking status associations with cell type-specific expression of mediators of SARS-CoV-2 viral entry and highlights inflammatory programs in putative target 
cells](https://www.biorxiv.org/content/10.1101/2020.04.19.049254v1)

[Interaction of drugs candidates with various SARS-CoV-2 receptors: an in silico study to combat COVID-19](https://chemrxiv.org/articles/Interaction_of_drugs_candidates_with_various_SARS-CoV-2_receptors_an_in_silico_study_to_combat_COVID-19/12100968/1)

[Is COVID-19 receiving ADE from other coronaviruses?](https://www.sciencedirect.com/science/article/pii/S1286457920300344)

[Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient](https://www.biorxiv.org/content/10.1101/2020.03.02.972935v2)

[Mechanistic modeling of the SARS-CoV-2 disease map](https://www.biorxiv.org/content/10.1101/2020.04.12.025577v1)
<p align="center">
    <a href="http://hipathia.babelomics.org/covid19/" title="See this resource">
      <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/CoV-Hipathia.png" width="30%"/>
    </a> 
</p>

[Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial](https://www.medrxiv.org/content/10.1101/2020.03.21.20040691v1)

[Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster in France reveals an amino-acid deletion in nsp2 (Asp268Del)](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142683/)

[Origin and evolution of pathogenic coronaviruses](https://www.nature.com/articles/s41579-018-0118-9)

[Pandemics: spend on surveillance, not prediction](https://www.nature.com/articles/d41586-018-05373-w)

[Persistent viral shedding of SARS-CoV-2 in faeces - a rapid review](https://www.medrxiv.org/content/10.1101/2020.04.17.20069526v1)

[Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2](https://www.sciencedirect.com/science/article/pii/S1286457920300496)

[Prisoners of war — host adaptation and its constraints on virus evolution](https://www.nature.com/articles/s41579-018-0120-2)

[Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak](https://linkinghub.elsevier.com/retrieve/pii/S0960-9822(20)30360-2)

[Ready, Set, Fuse! The Coronavirus Spike Protein and Acquisition of Fusion Competence](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347323/)

[Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus](https://jvi.asm.org/content/94/7/e00127-20)

[Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases](https://pubs.acs.org/doi/10.1021/acscentsci.0c00272)

[SARS Coronavirus Redux](https://www.sciencedirect.com/science/article/pii/S1471490620300387)

[SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor](https://www.sciencedirect.com/science/article/pii/S0092867420302294)

[SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes](https://www.nature.com/articles/s41591-020-0868-6?sf121476733=1)

[SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion](https://www.nature.com/articles/s41423-020-0424-9)

[SARS-CoV-2 invades host cells via a novel route: CD147-spike protein](https://www.biorxiv.org/content/10.1101/2020.03.14.988345v1)

[SARS-CoV-2 Life Cycle: Stages and Inhibition Targets](https://www.antibodies-online.com/resources/18/5410/sars-cov-2-life-cycle-stages-and-inhibition-targets/)

[SARS-CoV-2 productively infects human gut enterocytes](https://science.sciencemag.org/content/early/2020/04/30/science.abc1669)

[SARS-CoV-2 receptor ACE2 and TMPRSS2 are predominantly expressed in a transient secretory cell type in subsegmental bronchial branches](https://www.biorxiv.org/content/10.1101/2020.03.13.991455v3)

[SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells](https://www.ncbi.nlm.nih.gov/pubmed/32246845)

[Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade](https://www.karger.com/Article/FullText/507305)

[Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells](https://www.biorxiv.org/content/10.1101/2020.04.16.045617v1)

[Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir](https://science.sciencemag.org/content/early/2020/04/30/science.abc1560)

[Structural basis of receptor cognition by SARS-CoV-2](https://www.nature.com/articles/s41586-020-2179-y)

[Structural Basis of SARS-CoV-2 Spike Protein Priming by TMPRSS2](https://www.biorxiv.org/content/10.1101/2020.04.21.052639v1)

[Structural analysis of SARS-CoV-2 and predictions of the human interactome](https://www.biorxiv.org/content/10.1101/2020.03.28.013789v4.abstract?%3Fcollection=)

[Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease](https://www.biorxiv.org/content/10.1101/2020.04.10.036533v1)

[Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein](https://www.sciencedirect.com/science/article/pii/S0092867420302622)

[Structure of replicating SARS-CoV-2 polymerase](https://www.biorxiv.org/content/10.1101/2020.04.27.063180v1)

[Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor](https://www.nature.com/articles/s41586-020-2180-5)

[Susceptibility of ferrets, cats, dogs, and different domestic animals to SARS-coronavirus-2](https://www.biorxiv.org/content/10.1101/2020.03.30.015347v1)

[Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19](https://www.ijbs.com/v16p1724.htm)

[Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30196-1/fulltext)

[The biology of influenza viruses](https://www.sciencedirect.com/science/article/pii/S0264410X08009377)

[The insert sequence in SARS-CoV-2 enhances spike protein cleavage by TMPRSS](https://www.biorxiv.org/content/10.1101/2020.02.08.926006v3.full)

[The proximal origin of SARS-CoV-2](https://www.nature.com/articles/s41591-020-0820-9)

[The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement](https://www.biorxiv.org/content/10.1101/2020.04.10.036418v1)

[TMPRSS2 and ADAM17 Cleave ACE2 Differentially and Only Proteolysis by TMPRSS2 Augments Entry Driven by the Severe Acute Respiratory Syndrome Coronavirus Spike Protein](https://jvi.asm.org/content/88/2/1293.long)

[TMPRSS2 and TMPRSS4 mediate SARS-CoV-2 infection of human small intestinal enterocytes](https://www.biorxiv.org/content/10.1101/2020.04.21.054015v1)

[Tracking virus outbreaks in the twenty-first century](https://www.nature.com/articles/s41564-018-0296-2)

[Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools](https://link.springer.com/article/10.1007%2Fs12250-020-00207-4)

[Viral dynamics in mild and severe cases of COVID-19](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30232-2/fulltext)

[Viral load of SARS-CoV-2 in clinical samples](https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30113-4/fulltext)

[We shouldn’t worry when a virus mutates during disease outbreaks](https://www.nature.com/articles/s41564-020-0690-4)

[Why do RNA viruses recombine?](https://www.nature.com/articles/nrmicro2614)

[Widely available lysosome targeting agents should be considered as a potential therapy for COVID-19](https://www.preprints.org/manuscript/202003.0345/v2)

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>



<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Acknowledgements"></a>
## Acknowledgements ##
> Section to highlight the contributors of many links within this repository.
> Want to share your relevant links? Place a Direct Message to @resocios in Twitter.
<ul>
  <li>Agust&iacute;n Valenzuela Fern&aacute;ndez (ULL) <a href="https://twitter.com/SciArt3D" title="Follow to @SciArt3 on Twitter">@SciArt3</a></li>
  <li>Carlos Javier P&eacute;rez Gonz&aacute;lez (ULL) <a href="https://twitter.com/cpgonzal" title="Follow to @cpgonzal on Twitter">@cpgonzal</a></li>
  <li>Jos&eacute; Luis Roda (ULL) <a href="https://twitter.com/joluroga" title="Follow to @joluroga on Twitter">@joluroga</a></i>
  <li>Marcos Colebrook Santamar&iacute;a (ULL) <a href="https://twitter.com/MColebrook" title="Follow to @MColebrook on Twitter">@MColebrook</a></li>
  <li>Mar&iacute;a López P&eacute;rez (FIMERALL-SEGAI, ULL)</li>
  <li>Carlos Flores Infante (FIISC, ITER) <a href="https://twitter.com/LabCflores" title="Follow to @LabCflores on Twitter">@LabCflores</a></li>
  <li>Contributing PR to this repository, <a href="https://github.com/miguelcorrea" title="Follow to Miguel Correa on GitHub">Miguel Correa (@evocellnet, EMBL-EBI)</a></li>
</ul>

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Contact us"></a>
## Contact us ##
> Want to contact us? We highly encourage people to contribute to this COVID-19 repository (and acknowledged in the section above). Please, send me a Direct Message on Twitter (see below).

 <p align="left">
  <a href="https://www.iter.es/areas/area-genomica/" title="Contact us at the Genomics Division of the Institute of Technology and Renewable Energy (ITER), Tenerife, Canary Islands, Spain">
    <img src="https://www.iter.es/wp-content/uploads/2016/05/logo.png" width="30%" /> 
  </a>
</p>

Last update: 22:27 GMT - May 2, 2020     |     By JMLS <a href="https://twitter.com/resocios" title="Follow to @resocios on Twitter" >@resocios <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/Twitter_Social_Icon_Circle_Color.png" width="32px" /></a>

<hr>
<!-- ------------------ SECTION ------------------ -->

<a name="Update logs"></a>
## Update logs ##

> April 26, 2020 updates: new Epidemiology, Diagnostics, and Seroprevalence sections; 2 entries in Media section; 10 new entries in Virology section; 7 entries in the renamed 'Genomics and Phylodynamics' section; many (13) new entries in the PCR and related stuff (attention to new protocols and experiments for detecting the virus in sputum, use of 'dry-swabs', and saliva samples); more on funding opportunities; and some new data sources (3). Most of the entries now alphabetically sorted.

> April 21, 2020 updates: CRISPR–Cas12-based detection of SARS-CoV-2.

> April 20, 2020 updates: an alternative Illumina protocol for SARS sequencing (for Ct up to 38) in the Sequences & Sequencing section; new PCR fast detection method using a portable PCR thermocycler and comparative of PCR methods.

> April 19, 2020 updates: 67 new selected preprints and published papers in the Viral mechanisms section courtesy of Prof. A. Valenzuela (ULL).

> April 17-18, 2020 updates: new wiki structure in progress.

> April 16, 2020 updates: several entries in the Scientific Literature (Preprints & Published); and two new items in data sources.

> April 15, 2020 updates: added Databricks data collection; new CoV Genome Tracker; COVID-19 in Icelandic population; new records in the Education section; new articles about use and disinfection or repirators; more on virus mechanisms; new papers on COVID-19 detection techniques.

> April 14, 2020 updates: more on False Negatives in qPCR, impact of face mask against COVID-19, JAMA review of pharmacological treatments for COVID-19 in the Prepints section; added some Journals Watch pages; dashboard of the Spanish MoMo report about mortality, new dashboard for WHO, and new dashboard with graphical information for COVID-19 data in the Canary Islands by Grafcan-GOBCAN, in the Data Sources section; modeling of the SARS-CoV-2 disease map in the Viral mechanisms section; many new inputs in different sections (>20); new pages "Code of Conduct" and "Contributing to this repository" created.

> April 13, 2020 updates: few new articles in Scientific Literature (Pre-prints & Peer-Reviewed Papers) section and MIDAS COVID-19 repository in Data Sources section. As the repository increases its size, we are moving into a Wiki format (soon here!). Pull request by Miguel Correa added to the main branch of this repository.

> April 12, 2020 updates: new articles regarding COVID-19 detection, a comprehensive draft list of clinical trials by country from WHO (update April 11), dermatological effects of COVID-19, a new report from University of Göttingen, and many more.

> April 11, 2020 updates: new rapid PCR methods to detect COVID-19; warning about the use on non-specific PCR primers and False Negatives; more on the disinfection of respirators.

> April 10, 2020 updates: new logos; new papers in Scientic Literature; new subsection "Maths and Epidemiological Models", where the impact of social distancing and face mask use are presented.

> April 9, 2020 updates: new entries in the scientific literature section (PCR false negatives and COVID-19 affecting newborn babies, among others); new entry in the genomics section; new subsection dedicated to PCR and related topics within the Scientific Literature section; new articles related to respiratory protective equipment and ways to disinfect them; new section about sequencing and sequences.

<p align="right">
  <a href="#covid-19" title="Up">
    <img src="https://github.com/genomicsITER/COVID-19/blob/master/images/home-icon.png" style="float: right; margin: 10px; padding: 2px;" />
  </a>
</p>
